Signature	Cell type	Annotation	Pvalue	FDR
Disease-state	Naive CD4	Parkinson disease	1.3e-19	4.2e-17
Disease-state	Naive CD4	Oxidative phosphorylation	2.9e-15	4.7e-13
Disease-state	Naive CD4	Prion disease	5.8e-14	5.4e-12
Disease-state	Naive CD4	Pathways of neurodegeneration - multiple diseases	7.3e-14	5.4e-12
Disease-state	Naive CD4	Amyotrophic lateral sclerosis	8.4e-14	5.4e-12
Disease-state	Naive CD4	Alzheimer disease	5.1e-13	2.8e-11
Disease-state	Naive CD4	Proteasome	6.3e-13	2.9e-11
Disease-state	Naive CD4	Huntington disease	2.1e-11	8.3e-10
Disease-state	Naive CD4	Diabetic cardiomyopathy	2.8e-11	1e-09
Disease-state	Naive CD4	Chemical carcinogenesis - reactive oxygen species	4e-09	1.3e-07
Disease-state	Naive CD4	Non-alcoholic fatty liver disease	1e-08	3e-07
Disease-state	Naive CD4	Influenza A	2.2e-07	5.9e-06
Disease-state	Naive CD4	Thermogenesis	1.2e-06	2.9e-05
Disease-state	Naive CD4	Measles	3e-06	7e-05
Disease-state	Naive CD4	Epstein-Barr virus infection	4.5e-06	9.7e-05
Disease-state	Naive CD4	Herpes simplex virus 1 infection	6.6e-06	0.00013
Disease-state	Naive CD4	Hepatitis C	7.6e-06	0.00014
Disease-state	Naive CD4	Shigellosis	3.7e-05	0.00066
Disease-state	Naive CD4	Salmonella infection	0.00011	0.0018
Disease-state	Naive CD4	Pathogenic Escherichia coli infection	0.00011	0.0018
Disease-state	Naive CD4	Necroptosis	0.00015	0.0023
Disease-state	Naive CD4	Human immunodeficiency virus 1 infection	0.00018	0.0026
Disease-state	Naive CD4	Yersinia infection	0.00035	0.0049
Disease-state	Naive CD4	Cardiac muscle contraction	0.00037	0.0049
Disease-state	Naive CD4	Regulation of actin cytoskeleton	0.00078	0.01
Disease-state	Naive CD4	Spinocerebellar ataxia	0.0013	0.016
Disease-state	Naive CD4	Human cytomegalovirus infection	0.002	0.023
Disease-state	Naive CD4	Cytosolic DNA-sensing pathway	0.0029	0.034
Disease-state	Naive CD4	NOD-like receptor signaling pathway	0.0032	0.035
Disease-state	Naive CD4	Apoptosis	0.0035	0.038
Disease-state	Naive CD4	TNF signaling pathway	0.0042	0.044
Disease-state	Naive CD4	Protein processing in endoplasmic reticulum	0.0057	0.058
Disease-state	Naive CD4	Viral carcinogenesis	0.0061	0.059
Disease-state	Naive CD4	Retrograde endocannabinoid signaling	0.0072	0.069
Disease-state	Naive CD4	JAK-STAT signaling pathway	0.0083	0.075
Disease-state	Naive CD4	RIG-I-like receptor signaling pathway	0.0083	0.075
Disease-state	Naive CD4	Kaposi sarcoma-associated herpesvirus infection	0.0097	0.084
Disease-state	Naive CD4	Leukocyte transendothelial migration	0.01	0.084
Disease-state	Naive CD4	Neurotrophin signaling pathway	0.011	0.091
Disease-state	Naive CD4	Human T-cell leukemia virus 1 infection	0.012	0.1
Disease-state	Naive CD4	HIF-1 signaling pathway	0.013	0.1
Disease-state	Naive CD4	Bacterial invasion of epithelial cells	0.015	0.12
Disease-state	Naive CD4	Prolactin signaling pathway	0.02	0.15
Disease-state	Naive CD4	Glutathione metabolism	0.022	0.16
Disease-state	Naive CD4	Chemokine signaling pathway	0.022	0.16
Disease-state	Naive CD4	Antigen processing and presentation	0.027	0.19
Disease-state	Naive CD4	Pertussis	0.03	0.21
Disease-state	Naive CD4	Protein export	0.034	0.23
Disease-state	Naive CD4	Lipid and atherosclerosis	0.036	0.24
Disease-state	Naive CD4	Cocaine addiction	0.04	0.26
Disease-state	Naive CD4	PI3K-Akt signaling pathway	0.044	0.28
Disease-state	Naive CD4	Vibrio cholerae infection	0.047	0.28
Disease-state	Naive CD4	Fc gamma R-mediated phagocytosis	0.047	0.28
Disease-state	Naive CD4	NF-kappa B signaling pathway	0.047	0.28
Disease-state	Naive CD4	Pathways in cancer	0.049	0.28
Disease-state	Naive CD4	Human papillomavirus infection	0.049	0.28
Disease-state	Mem CD4	Proteasome	3.1e-13	1e-10
Disease-state	Mem CD4	Parkinson disease	2.6e-11	4.2e-09
Disease-state	Mem CD4	Prion disease	1.1e-10	1.1e-08
Disease-state	Mem CD4	Epstein-Barr virus infection	2.6e-10	2.1e-08
Disease-state	Mem CD4	Pathways of neurodegeneration - multiple diseases	1.2e-09	8e-08
Disease-state	Mem CD4	Huntington disease	3.5e-09	1.9e-07
Disease-state	Mem CD4	Oxidative phosphorylation	5.1e-09	2.3e-07
Disease-state	Mem CD4	Amyotrophic lateral sclerosis	4.7e-08	1.9e-06
Disease-state	Mem CD4	Alzheimer disease	8.3e-08	3e-06
Disease-state	Mem CD4	Antigen processing and presentation	1.8e-07	5.7e-06
Disease-state	Mem CD4	Influenza A	3.3e-07	9.7e-06
Disease-state	Mem CD4	Diabetic cardiomyopathy	6.9e-07	1.8e-05
Disease-state	Mem CD4	Human immunodeficiency virus 1 infection	7.3e-06	0.00018
Disease-state	Mem CD4	Viral myocarditis	8.3e-06	0.00019
Disease-state	Mem CD4	Measles	1.6e-05	0.00035
Disease-state	Mem CD4	Type I diabetes mellitus	2.5e-05	0.0005
Disease-state	Mem CD4	Human cytomegalovirus infection	3.3e-05	0.00063
Disease-state	Mem CD4	Autoimmune thyroid disease	4.1e-05	0.00066
Disease-state	Mem CD4	Allograft rejection	4.1e-05	0.00066
Disease-state	Mem CD4	Graft-versus-host disease	4.1e-05	0.00066
Disease-state	Mem CD4	Shigellosis	6.5e-05	0.001
Disease-state	Mem CD4	Non-alcoholic fatty liver disease	6.9e-05	0.001
Disease-state	Mem CD4	Chemical carcinogenesis - reactive oxygen species	0.00013	0.0019
Disease-state	Mem CD4	Spinocerebellar ataxia	0.00015	0.002
Disease-state	Mem CD4	Th17 cell differentiation	0.00015	0.002
Disease-state	Mem CD4	Leukocyte transendothelial migration	0.00017	0.0021
Disease-state	Mem CD4	Inflammatory bowel disease	0.00024	0.0029
Disease-state	Mem CD4	Chemokine signaling pathway	0.00027	0.0031
Disease-state	Mem CD4	Yersinia infection	0.00031	0.0034
Disease-state	Mem CD4	Viral carcinogenesis	0.00059	0.0063
Disease-state	Mem CD4	Hepatitis C	0.0009	0.0093
Disease-state	Mem CD4	NOD-like receptor signaling pathway	0.0012	0.012
Disease-state	Mem CD4	Rheumatoid arthritis	0.0015	0.014
Disease-state	Mem CD4	Thermogenesis	0.0016	0.015
Disease-state	Mem CD4	Regulation of actin cytoskeleton	0.0016	0.015
Disease-state	Mem CD4	Cytosolic DNA-sensing pathway	0.0023	0.02
Disease-state	Mem CD4	Central carbon metabolism in cancer	0.0035	0.03
Disease-state	Mem CD4	Toxoplasmosis	0.0036	0.031
Disease-state	Mem CD4	Intestinal immune network for IgA production	0.0042	0.034
Disease-state	Mem CD4	Th1 and Th2 cell differentiation	0.0043	0.034
Disease-state	Mem CD4	Neurotrophin signaling pathway	0.0043	0.034
Disease-state	Mem CD4	Apoptosis - multiple species	0.0059	0.043
Disease-state	Mem CD4	Cardiac muscle contraction	0.0059	0.043
Disease-state	Mem CD4	JAK-STAT signaling pathway	0.0059	0.043
Disease-state	Mem CD4	Hematopoietic cell lineage	0.0061	0.043
Disease-state	Mem CD4	Kaposi sarcoma-associated herpesvirus infection	0.0062	0.043
Disease-state	Mem CD4	Protein processing in endoplasmic reticulum	0.0066	0.046
Disease-state	Mem CD4	Herpes simplex virus 1 infection	0.0085	0.056
Disease-state	Mem CD4	Pathways in cancer	0.0086	0.056
Disease-state	Mem CD4	Asthma	0.0088	0.056
Disease-state	Mem CD4	Citrate cycle (TCA cycle)	0.0094	0.059
Disease-state	Mem CD4	Lipid and atherosclerosis	0.0096	0.059
Disease-state	Mem CD4	Platinum drug resistance	0.012	0.076
Disease-state	Mem CD4	Necroptosis	0.015	0.087
Disease-state	Mem CD4	Epithelial cell signaling in Helicobacter pylori infection	0.015	0.087
Disease-state	Mem CD4	Salmonella infection	0.016	0.09
Disease-state	Mem CD4	C-type lectin receptor signaling pathway	0.016	0.09
Disease-state	Mem CD4	Toll-like receptor signaling pathway	0.023	0.13
Disease-state	Mem CD4	Cholinergic synapse	0.024	0.13
Disease-state	Mem CD4	Morphine addiction	0.026	0.14
Disease-state	Mem CD4	PPAR signaling pathway	0.038	0.2
Disease-state	Mem CD4	Bacterial invasion of epithelial cells	0.042	0.22
Disease-state	Mem CD4	PD-L1 expression and PD-1 checkpoint pathway in cancer	0.042	0.22
Disease-state	Mem CD4	Tuberculosis	0.044	0.22
Disease-state	Mem CD4	Fc gamma R-mediated phagocytosis	0.047	0.23
Disease-state	Mem CD4	Cell adhesion molecules	0.047	0.23
Disease-state	Th1	Parkinson disease	5.2e-18	1.7e-15
Disease-state	Th1	Proteasome	1.4e-16	2.2e-14
Disease-state	Th1	Prion disease	4.7e-14	5.1e-12
Disease-state	Th1	Pathways of neurodegeneration - multiple diseases	8.5e-11	6.9e-09
Disease-state	Th1	Oxidative phosphorylation	1.6e-10	1e-08
Disease-state	Th1	Amyotrophic lateral sclerosis	4.7e-10	2.6e-08
Disease-state	Th1	Huntington disease	8.3e-10	3.9e-08
Disease-state	Th1	Alzheimer disease	4.6e-09	1.9e-07
Disease-state	Th1	Diabetic cardiomyopathy	6.3e-09	2.3e-07
Disease-state	Th1	Epstein-Barr virus infection	3.7e-08	1.2e-06
Disease-state	Th1	Cell cycle	4.8e-08	1.4e-06
Disease-state	Th1	Influenza A	2.7e-06	7.3e-05
Disease-state	Th1	Thermogenesis	2.8e-05	0.00071
Disease-state	Th1	Viral carcinogenesis	5e-05	0.0012
Disease-state	Th1	Chemical carcinogenesis - reactive oxygen species	9.1e-05	0.002
Disease-state	Th1	Human immunodeficiency virus 1 infection	0.0001	0.002
Disease-state	Th1	Hepatitis C	0.00014	0.0027
Disease-state	Th1	Non-alcoholic fatty liver disease	0.00015	0.0028
Disease-state	Th1	Spinocerebellar ataxia	0.00018	0.0031
Disease-state	Th1	Oocyte meiosis	0.00032	0.0048
Disease-state	Th1	Biosynthesis of amino acids	0.00033	0.0048
Disease-state	Th1	Inflammatory bowel disease	0.00033	0.0048
Disease-state	Th1	Antigen processing and presentation	0.00041	0.0058
Disease-state	Th1	Human cytomegalovirus infection	0.00069	0.0093
Disease-state	Th1	DNA replication	0.00071	0.0093
Disease-state	Th1	Cellular senescence	0.0022	0.027
Disease-state	Th1	Fanconi anemia pathway	0.0029	0.034
Disease-state	Th1	p53 signaling pathway	0.0029	0.034
Disease-state	Th1	Autoimmune thyroid disease	0.0033	0.035
Disease-state	Th1	Allograft rejection	0.0033	0.035
Disease-state	Th1	Graft-versus-host disease	0.0033	0.035
Disease-state	Th1	Neurotrophin signaling pathway	0.0036	0.036
Disease-state	Th1	Morphine addiction	0.0038	0.037
Disease-state	Th1	Retrograde endocannabinoid signaling	0.0039	0.037
Disease-state	Th1	Regulation of actin cytoskeleton	0.004	0.037
Disease-state	Th1	Chemokine signaling pathway	0.0042	0.038
Disease-state	Th1	Measles	0.0043	0.038
Disease-state	Th1	Leukocyte transendothelial migration	0.0047	0.041
Disease-state	Th1	Cysteine and methionine metabolism	0.0062	0.052
Disease-state	Th1	Type I diabetes mellitus	0.0065	0.052
Disease-state	Th1	Circadian entrainment	0.0066	0.052
Disease-state	Th1	Shigellosis	0.0067	0.052
Disease-state	Th1	Asthma	0.007	0.053
Disease-state	Th1	Glucagon signaling pathway	0.0095	0.07
Disease-state	Th1	One carbon pool by folate	0.0098	0.071
Disease-state	Th1	Bacterial invasion of epithelial cells	0.013	0.091
Disease-state	Th1	MicroRNAs in cancer	0.014	0.097
Disease-state	Th1	Glutathione metabolism	0.014	0.097
Disease-state	Th1	Olfactory transduction	0.015	0.1
Disease-state	Th1	Platinum drug resistance	0.016	0.1
Disease-state	Th1	Th1 and Th2 cell differentiation	0.016	0.1
Disease-state	Th1	Intestinal immune network for IgA production	0.018	0.11
Disease-state	Th1	Toxoplasmosis	0.018	0.11
Disease-state	Th1	Apoptosis - multiple species	0.02	0.12
Disease-state	Th1	Human T-cell leukemia virus 1 infection	0.021	0.12
Disease-state	Th1	Glioma	0.021	0.12
Disease-state	Th1	Endocytosis	0.022	0.12
Disease-state	Th1	Apoptosis	0.023	0.13
Disease-state	Th1	Dopaminergic synapse	0.025	0.14
Disease-state	Th1	Cardiac muscle contraction	0.026	0.14
Disease-state	Th1	JAK-STAT signaling pathway	0.028	0.15
Disease-state	Th1	Citrate cycle (TCA cycle)	0.028	0.15
Disease-state	Th1	Viral myocarditis	0.029	0.15
Disease-state	Th1	Th17 cell differentiation	0.03	0.15
Disease-state	Th1	Pathways in cancer	0.03	0.15
Disease-state	Th1	GABAergic synapse	0.032	0.16
Disease-state	Th1	Human papillomavirus infection	0.032	0.16
Disease-state	Th1	Small cell lung cancer	0.033	0.16
Disease-state	Th1	Homologous recombination	0.036	0.17
Disease-state	Th1	2-Oxocarboxylic acid metabolism	0.036	0.17
Disease-state	Th1	Cholinergic synapse	0.036	0.17
Disease-state	Th1	Central carbon metabolism in cancer	0.038	0.17
Disease-state	Th1	Necroptosis	0.045	0.2
Disease-state	Th1	Gastric acid secretion	0.049	0.21
Disease-state	Th2	Hepatitis C	3.5e-09	1.1e-06
Disease-state	Th2	Measles	1.2e-08	1.9e-06
Disease-state	Th2	Influenza A	6.5e-08	7e-06
Disease-state	Th2	Proteasome	1.2e-06	9.8e-05
Disease-state	Th2	Pathways in cancer	4.9e-06	0.00031
Disease-state	Th2	Cytokine-cytokine receptor interaction	8.9e-06	0.00047
Disease-state	Th2	Epstein-Barr virus infection	1.3e-05	0.00058
Disease-state	Th2	Parkinson disease	2.2e-05	0.00086
Disease-state	Th2	Alzheimer disease	9.9e-05	0.0035
Disease-state	Th2	Colorectal cancer	0.00014	0.0044
Disease-state	Th2	Inflammatory bowel disease	0.00015	0.0044
Disease-state	Th2	NOD-like receptor signaling pathway	0.0002	0.0053
Disease-state	Th2	Cardiac muscle contraction	0.00025	0.0063
Disease-state	Th2	JAK-STAT signaling pathway	0.0003	0.0064
Disease-state	Th2	Apoptosis - multiple species	0.0003	0.0064
Disease-state	Th2	Prion disease	0.0006	0.012
Disease-state	Th2	Apoptosis	0.0011	0.02
Disease-state	Th2	Pathways of neurodegeneration - multiple diseases	0.0013	0.022
Disease-state	Th2	Thyroid cancer	0.0013	0.023
Disease-state	Th2	Diabetic cardiomyopathy	0.0015	0.024
Disease-state	Th2	Oxidative phosphorylation	0.0018	0.027
Disease-state	Th2	Human immunodeficiency virus 1 infection	0.0021	0.03
Disease-state	Th2	p53 signaling pathway	0.0022	0.03
Disease-state	Th2	Hepatitis B	0.0027	0.036
Disease-state	Th2	Shigellosis	0.0029	0.037
Disease-state	Th2	Chemical carcinogenesis - reactive oxygen species	0.0041	0.047
Disease-state	Th2	Toxoplasmosis	0.0041	0.047
Disease-state	Th2	Non-alcoholic fatty liver disease	0.0044	0.047
Disease-state	Th2	Autoimmune thyroid disease	0.0045	0.047
Disease-state	Th2	Chemokine signaling pathway	0.0045	0.047
Disease-state	Th2	Th17 cell differentiation	0.0046	0.047
Disease-state	Th2	Huntington disease	0.0049	0.049
Disease-state	Th2	Bladder cancer	0.0059	0.057
Disease-state	Th2	Necroptosis	0.0061	0.058
Disease-state	Th2	Amyotrophic lateral sclerosis	0.0068	0.062
Disease-state	Th2	PI3K-Akt signaling pathway	0.0074	0.066
Disease-state	Th2	Human cytomegalovirus infection	0.0095	0.082
Disease-state	Th2	Chronic myeloid leukemia	0.01	0.086
Disease-state	Th2	Kaposi sarcoma-associated herpesvirus infection	0.011	0.09
Disease-state	Th2	Hematopoietic cell lineage	0.014	0.11
Disease-state	Th2	Type I diabetes mellitus	0.021	0.16
Disease-state	Th2	Leukocyte transendothelial migration	0.021	0.16
Disease-state	Th2	Small cell lung cancer	0.021	0.16
Disease-state	Th2	TGF-beta signaling pathway	0.022	0.16
Disease-state	Th2	Viral carcinogenesis	0.023	0.17
Disease-state	Th2	Pathogenic Escherichia coli infection	0.024	0.17
Disease-state	Th2	Antigen processing and presentation	0.026	0.18
Disease-state	Th2	Spinocerebellar ataxia	0.031	0.2
Disease-state	Th2	Th1 and Th2 cell differentiation	0.032	0.2
Disease-state	Th2	RIG-I-like receptor signaling pathway	0.032	0.2
Disease-state	Th2	Fatty acid elongation	0.033	0.21
Disease-state	Th2	Acute myeloid leukemia	0.034	0.21
Disease-state	Th2	Graft-versus-host disease	0.034	0.21
Disease-state	Th2	Viral protein interaction with cytokine and cytokine receptor	0.035	0.21
Disease-state	Th2	Arrhythmogenic right ventricular cardiomyopathy	0.036	0.21
Disease-state	Th2	FoxO signaling pathway	0.039	0.22
Disease-state	Th2	Platinum drug resistance	0.039	0.22
Disease-state	Th2	Ovarian steroidogenesis	0.041	0.23
Disease-state	Th2	GABAergic synapse	0.042	0.23
Disease-state	Th2	Dilated cardiomyopathy	0.044	0.24
Disease-state	Th2	Endocytosis	0.046	0.24
Disease-state	Th17	Measles	1.8e-09	5.2e-07
Disease-state	Th17	Influenza A	2.4e-08	3.4e-06
Disease-state	Th17	JAK-STAT signaling pathway	1.6e-07	1.2e-05
Disease-state	Th17	Hepatitis C	1.7e-07	1.2e-05
Disease-state	Th17	NOD-like receptor signaling pathway	7e-06	0.0004
Disease-state	Th17	Cytokine-cytokine receptor interaction	0.00023	0.0095
Disease-state	Th17	Epstein-Barr virus infection	0.00023	0.0095
Disease-state	Th17	Necroptosis	0.0004	0.014
Disease-state	Th17	Coronavirus disease - COVID-19	0.00069	0.021
Disease-state	Th17	PI3K-Akt signaling pathway	0.00079	0.021
Disease-state	Th17	p53 signaling pathway	0.0008	0.021
Disease-state	Th17	RIG-I-like receptor signaling pathway	0.00093	0.022
Disease-state	Th17	NF-kappa B signaling pathway	0.0012	0.027
Disease-state	Th17	Pathways in cancer	0.0021	0.043
Disease-state	Th17	Pancreatic cancer	0.0034	0.065
Disease-state	Th17	Hepatitis B	0.005	0.089
Disease-state	Th17	Cytosolic DNA-sensing pathway	0.0074	0.12
Disease-state	Th17	Toxoplasmosis	0.0075	0.12
Disease-state	Th17	TGF-beta signaling pathway	0.0086	0.13
Disease-state	Th17	Osteoclast differentiation	0.011	0.15
Disease-state	Th17	Chronic myeloid leukemia	0.012	0.17
Disease-state	Th17	Th17 cell differentiation	0.013	0.17
Disease-state	Th17	Shigellosis	0.014	0.17
Disease-state	Th17	Thyroid cancer	0.014	0.17
Disease-state	Th17	Hematopoietic cell lineage	0.015	0.17
Disease-state	Th17	Bladder cancer	0.016	0.18
Disease-state	Th17	Pathogenic Escherichia coli infection	0.018	0.19
Disease-state	Th17	Small cell lung cancer	0.019	0.19
Disease-state	Th17	Transcriptional misregulation in cancer	0.02	0.19
Disease-state	Th17	Kaposi sarcoma-associated herpesvirus infection	0.02	0.19
Disease-state	Th17	Viral carcinogenesis	0.031	0.28
Disease-state	Th17	Acute myeloid leukemia	0.033	0.29
Disease-state	Th17	Adipocytokine signaling pathway	0.036	0.31
Disease-state	Th17	Human T-cell leukemia virus 1 infection	0.038	0.31
Disease-state	Th17	HIF-1 signaling pathway	0.038	0.31
Disease-state	Th17	Apoptosis	0.039	0.31
Disease-state	Th17	Insulin resistance	0.041	0.31
Disease-state	Th17	Intestinal immune network for IgA production	0.043	0.32
Disease-state	Th17	MicroRNAs in cancer	0.045	0.33
Disease-state	Th17	Viral protein interaction with cytokine and cytokine receptor	0.049	0.34
Disease-state	Th17	Arginine and proline metabolism	0.05	0.34
Disease-state	Tfh	Influenza A	5.2e-14	1.6e-11
Disease-state	Tfh	Hepatitis C	3.1e-08	4.8e-06
Disease-state	Tfh	Epstein-Barr virus infection	4.7e-08	4.8e-06
Disease-state	Tfh	Inflammatory bowel disease	7.1e-08	5.6e-06
Disease-state	Tfh	JAK-STAT signaling pathway	5e-07	3.1e-05
Disease-state	Tfh	Cytokine-cytokine receptor interaction	7.7e-07	4e-05
Disease-state	Tfh	Th17 cell differentiation	9.1e-07	4e-05
Disease-state	Tfh	Toxoplasmosis	2.5e-06	9.6e-05
Disease-state	Tfh	Measles	8e-06	0.00028
Disease-state	Tfh	Pathways in cancer	1.6e-05	0.00048
Disease-state	Tfh	Leishmaniasis	4.1e-05	0.0011
Disease-state	Tfh	Human T-cell leukemia virus 1 infection	4.5e-05	0.0011
Disease-state	Tfh	Antigen processing and presentation	4.8e-05	0.0011
Disease-state	Tfh	NOD-like receptor signaling pathway	5.2e-05	0.0011
Disease-state	Tfh	Human cytomegalovirus infection	0.00015	0.0032
Disease-state	Tfh	Necroptosis	0.00019	0.0037
Disease-state	Tfh	Intestinal immune network for IgA production	0.0002	0.0037
Disease-state	Tfh	Tuberculosis	0.00023	0.004
Disease-state	Tfh	Type I diabetes mellitus	0.00034	0.0056
Disease-state	Tfh	Chemokine signaling pathway	0.00041	0.0063
Disease-state	Tfh	Th1 and Th2 cell differentiation	0.00057	0.0084
Disease-state	Tfh	Autoimmune thyroid disease	0.00072	0.01
Disease-state	Tfh	Leukocyte transendothelial migration	0.00085	0.011
Disease-state	Tfh	Kaposi sarcoma-associated herpesvirus infection	0.001	0.013
Disease-state	Tfh	Hematopoietic cell lineage	0.0013	0.016
Disease-state	Tfh	Lipid and atherosclerosis	0.0013	0.016
Disease-state	Tfh	HIF-1 signaling pathway	0.0016	0.019
Disease-state	Tfh	Viral protein interaction with cytokine and cytokine receptor	0.002	0.022
Disease-state	Tfh	Hepatitis B	0.0024	0.024
Disease-state	Tfh	PI3K-Akt signaling pathway	0.0025	0.024
Disease-state	Tfh	Cytosolic DNA-sensing pathway	0.0025	0.024
Disease-state	Tfh	Viral carcinogenesis	0.0026	0.024
Disease-state	Tfh	Allograft rejection	0.0027	0.024
Disease-state	Tfh	Graft-versus-host disease	0.0027	0.024
Disease-state	Tfh	Apoptosis	0.0028	0.024
Disease-state	Tfh	Human immunodeficiency virus 1 infection	0.0028	0.025
Disease-state	Tfh	Cholinergic synapse	0.0032	0.027
Disease-state	Tfh	Shigellosis	0.0041	0.034
Disease-state	Tfh	RIG-I-like receptor signaling pathway	0.0056	0.045
Disease-state	Tfh	Transcriptional misregulation in cancer	0.0063	0.049
Disease-state	Tfh	Toll-like receptor signaling pathway	0.01	0.077
Disease-state	Tfh	Pathogenic Escherichia coli infection	0.01	0.077
Disease-state	Tfh	Proteasome	0.011	0.077
Disease-state	Tfh	Bladder cancer	0.011	0.078
Disease-state	Tfh	Asthma	0.012	0.082
Disease-state	Tfh	TGF-beta signaling pathway	0.018	0.12
Disease-state	Tfh	Pancreatic cancer	0.02	0.13
Disease-state	Tfh	Colorectal cancer	0.023	0.15
Disease-state	Tfh	Chagas disease	0.024	0.15
Disease-state	Tfh	FoxO signaling pathway	0.024	0.15
Disease-state	Tfh	Staphylococcus aureus infection	0.025	0.15
Disease-state	Tfh	MicroRNAs in cancer	0.025	0.15
Disease-state	Tfh	Cell cycle	0.026	0.15
Disease-state	Tfh	Cell adhesion molecules	0.027	0.15
Disease-state	Tfh	Gastric cancer	0.03	0.17
Disease-state	Tfh	NF-kappa B signaling pathway	0.03	0.17
Disease-state	Tfh	Central carbon metabolism in cancer	0.03	0.17
Disease-state	Tfh	Apoptosis - multiple species	0.032	0.17
Disease-state	Tfh	p53 signaling pathway	0.032	0.17
Disease-state	Tfh	Steroid biosynthesis	0.033	0.17
Disease-state	Tfh	Viral myocarditis	0.033	0.17
Disease-state	Tfh	Type II diabetes mellitus	0.039	0.19
Disease-state	Tfh	Herpes simplex virus 1 infection	0.039	0.19
Disease-state	Tfh	One carbon pool by folate	0.04	0.19
Disease-state	Tfh	AGE-RAGE signaling pathway in diabetic complications	0.041	0.2
Disease-state	Tfh	Glycolysis / Gluconeogenesis	0.042	0.2
Disease-state	Tfh	Human papillomavirus infection	0.045	0.21
Disease-state	Tfh	Small cell lung cancer	0.046	0.21
Disease-state	Tfh	Salmonella infection	0.049	0.22
Disease-state	Tfh	Protein processing in endoplasmic reticulum	0.049	0.22
Disease-state	Tfh	Osteoclast differentiation	0.05	0.22
Disease-state	Fr. I nTreg	Parkinson disease	3.7e-13	1.2e-10
Disease-state	Fr. I nTreg	Proteasome	9.8e-11	1.5e-08
Disease-state	Fr. I nTreg	Prion disease	9e-10	9.5e-08
Disease-state	Fr. I nTreg	Alzheimer disease	4.2e-08	3.3e-06
Disease-state	Fr. I nTreg	Amyotrophic lateral sclerosis	1.3e-07	8.2e-06
Disease-state	Fr. I nTreg	Pathways of neurodegeneration - multiple diseases	1.7e-07	8.7e-06
Disease-state	Fr. I nTreg	Influenza A	3.7e-06	0.00017
Disease-state	Fr. I nTreg	Huntington disease	6.3e-06	0.00025
Disease-state	Fr. I nTreg	Hepatitis C	9.7e-06	0.00034
Disease-state	Fr. I nTreg	NOD-like receptor signaling pathway	1.5e-05	0.00048
Disease-state	Fr. I nTreg	Oxidative phosphorylation	4.5e-05	0.0013
Disease-state	Fr. I nTreg	Non-alcoholic fatty liver disease	5.8e-05	0.0015
Disease-state	Fr. I nTreg	Measles	6.4e-05	0.0015
Disease-state	Fr. I nTreg	Necroptosis	9.2e-05	0.0021
Disease-state	Fr. I nTreg	Diabetic cardiomyopathy	0.00033	0.0069
Disease-state	Fr. I nTreg	Epstein-Barr virus infection	0.00056	0.011
Disease-state	Fr. I nTreg	JAK-STAT signaling pathway	0.00057	0.011
Disease-state	Fr. I nTreg	Hepatitis B	0.0015	0.026
Disease-state	Fr. I nTreg	Spinocerebellar ataxia	0.002	0.034
Disease-state	Fr. I nTreg	Chemical carcinogenesis - reactive oxygen species	0.0031	0.049
Disease-state	Fr. I nTreg	Thermogenesis	0.004	0.061
Disease-state	Fr. I nTreg	Human immunodeficiency virus 1 infection	0.0047	0.068
Disease-state	Fr. I nTreg	Apoptosis	0.0057	0.078
Disease-state	Fr. I nTreg	Salmonella infection	0.0061	0.078
Disease-state	Fr. I nTreg	Cellular senescence	0.0062	0.078
Disease-state	Fr. I nTreg	Biosynthesis of amino acids	0.0066	0.08
Disease-state	Fr. I nTreg	Human cytomegalovirus infection	0.007	0.082
Disease-state	Fr. I nTreg	TGF-beta signaling pathway	0.0079	0.089
Disease-state	Fr. I nTreg	Human T-cell leukemia virus 1 infection	0.0085	0.092
Disease-state	Fr. I nTreg	Retrograde endocannabinoid signaling	0.0097	0.1
Disease-state	Fr. I nTreg	NF-kappa B signaling pathway	0.011	0.11
Disease-state	Fr. I nTreg	Osteoclast differentiation	0.015	0.15
Disease-state	Fr. I nTreg	Cardiac muscle contraction	0.016	0.15
Disease-state	Fr. I nTreg	Kaposi sarcoma-associated herpesvirus infection	0.017	0.15
Disease-state	Fr. I nTreg	Apoptosis - multiple species	0.02	0.18
Disease-state	Fr. I nTreg	Viral carcinogenesis	0.02	0.18
Disease-state	Fr. I nTreg	HIF-1 signaling pathway	0.023	0.19
Disease-state	Fr. I nTreg	Carbon metabolism	0.023	0.19
Disease-state	Fr. I nTreg	Prolactin signaling pathway	0.025	0.2
Disease-state	Fr. I nTreg	Insulin resistance	0.025	0.2
Disease-state	Fr. I nTreg	Pertussis	0.028	0.21
Disease-state	Fr. I nTreg	Toxoplasmosis	0.029	0.21
Disease-state	Fr. I nTreg	Chronic myeloid leukemia	0.03	0.21
Disease-state	Fr. I nTreg	RIG-I-like receptor signaling pathway	0.03	0.21
Disease-state	Fr. I nTreg	Endocytosis	0.03	0.21
Disease-state	Fr. I nTreg	Parathyroid hormone synthesis, secretion and action	0.032	0.22
Disease-state	Fr. I nTreg	Th17 cell differentiation	0.034	0.23
Disease-state	Fr. I nTreg	p53 signaling pathway	0.035	0.23
Disease-state	Fr. I nTreg	Circadian rhythm	0.036	0.23
Disease-state	Fr. I nTreg	FoxO signaling pathway	0.036	0.23
Disease-state	Fr. I nTreg	Renin secretion	0.037	0.23
Disease-state	Fr. I nTreg	Pathways in cancer	0.038	0.23
Disease-state	Fr. I nTreg	Pancreatic cancer	0.045	0.27
Disease-state	Fr. I nTreg	AGE-RAGE signaling pathway in diabetic complications	0.047	0.28
Disease-state	Fr. II eTreg	Measles	3.6e-09	1.1e-06
Disease-state	Fr. II eTreg	Influenza A	2e-08	3.1e-06
Disease-state	Fr. II eTreg	Hepatitis C	7.3e-06	0.00073
Disease-state	Fr. II eTreg	JAK-STAT signaling pathway	1.2e-05	0.00092
Disease-state	Fr. II eTreg	NOD-like receptor signaling pathway	4.4e-05	0.0026
Disease-state	Fr. II eTreg	Lipid and atherosclerosis	0.00013	0.0067
Disease-state	Fr. II eTreg	NF-kappa B signaling pathway	0.00018	0.0077
Disease-state	Fr. II eTreg	HIF-1 signaling pathway	0.00024	0.0091
Disease-state	Fr. II eTreg	Cytokine-cytokine receptor interaction	0.00028	0.0094
Disease-state	Fr. II eTreg	Epstein-Barr virus infection	0.00039	0.012
Disease-state	Fr. II eTreg	Necroptosis	0.00058	0.016
Disease-state	Fr. II eTreg	p53 signaling pathway	0.0011	0.027
Disease-state	Fr. II eTreg	Protein processing in endoplasmic reticulum	0.0015	0.035
Disease-state	Fr. II eTreg	Viral protein interaction with cytokine and cytokine receptor	0.0023	0.051
Disease-state	Fr. II eTreg	Toll-like receptor signaling pathway	0.0029	0.059
Disease-state	Fr. II eTreg	TNF signaling pathway	0.0033	0.063
Disease-state	Fr. II eTreg	Apoptosis - multiple species	0.0037	0.067
Disease-state	Fr. II eTreg	Transcriptional misregulation in cancer	0.0062	0.1
Disease-state	Fr. II eTreg	Pathways in cancer	0.0065	0.1
Disease-state	Fr. II eTreg	Apoptosis	0.0084	0.12
Disease-state	Fr. II eTreg	Toxoplasmosis	0.0085	0.12
Disease-state	Fr. II eTreg	Cytosolic DNA-sensing pathway	0.0093	0.12
Disease-state	Fr. II eTreg	Salmonella infection	0.0094	0.12
Disease-state	Fr. II eTreg	Kaposi sarcoma-associated herpesvirus infection	0.012	0.15
Disease-state	Fr. II eTreg	IL-17 signaling pathway	0.015	0.18
Disease-state	Fr. II eTreg	Hepatitis B	0.016	0.18
Disease-state	Fr. II eTreg	RIG-I-like receptor signaling pathway	0.017	0.19
Disease-state	Fr. II eTreg	Type II diabetes mellitus	0.017	0.19
Disease-state	Fr. II eTreg	Small cell lung cancer	0.023	0.24
Disease-state	Fr. II eTreg	cAMP signaling pathway	0.024	0.24
Disease-state	Fr. II eTreg	Human cytomegalovirus infection	0.024	0.24
Disease-state	Fr. II eTreg	PD-L1 expression and PD-1 checkpoint pathway in cancer	0.025	0.24
Disease-state	Fr. II eTreg	Coronavirus disease - COVID-19	0.026	0.24
Disease-state	Fr. II eTreg	Insulin resistance	0.027	0.24
Disease-state	Fr. II eTreg	Viral carcinogenesis	0.037	0.32
Disease-state	Fr. II eTreg	MAPK signaling pathway	0.04	0.34
Disease-state	Fr. III T	Coronavirus disease - COVID-19	8.4e-09	2.7e-06
Disease-state	Fr. III T	Influenza A	4e-06	0.00065
Disease-state	Fr. III T	Measles	2.7e-05	0.0029
Disease-state	Fr. III T	JAK-STAT signaling pathway	3.6e-05	0.0029
Disease-state	Fr. III T	Hepatitis C	6.4e-05	0.0041
Disease-state	Fr. III T	Ribosome	0.00027	0.015
Disease-state	Fr. III T	HIF-1 signaling pathway	0.00037	0.017
Disease-state	Fr. III T	Necroptosis	0.0019	0.075
Disease-state	Fr. III T	Pathways in cancer	0.0025	0.087
Disease-state	Fr. III T	IL-17 signaling pathway	0.0027	0.087
Disease-state	Fr. III T	RIG-I-like receptor signaling pathway	0.0032	0.093
Disease-state	Fr. III T	Epstein-Barr virus infection	0.0062	0.16
Disease-state	Fr. III T	Mucin type O-glycan biosynthesis	0.0089	0.19
Disease-state	Fr. III T	FoxO signaling pathway	0.0092	0.19
Disease-state	Fr. III T	Notch signaling pathway	0.0092	0.19
Disease-state	Fr. III T	Protein processing in endoplasmic reticulum	0.0095	0.19
Disease-state	Fr. III T	Hepatitis B	0.013	0.25
Disease-state	Fr. III T	mTOR signaling pathway	0.015	0.27
Disease-state	Fr. III T	NOD-like receptor signaling pathway	0.017	0.27
Disease-state	Fr. III T	NF-kappa B signaling pathway	0.018	0.27
Disease-state	Fr. III T	Legionellosis	0.018	0.27
Disease-state	Fr. III T	Prostate cancer	0.018	0.27
Disease-state	Fr. III T	Glycosaminoglycan biosynthesis - keratan sulfate	0.019	0.27
Disease-state	Fr. III T	Acute myeloid leukemia	0.026	0.32
Disease-state	Fr. III T	TNF signaling pathway	0.026	0.32
Disease-state	Fr. III T	Glycosphingolipid biosynthesis - lacto and neolacto series	0.027	0.32
Disease-state	Fr. III T	Insulin signaling pathway	0.027	0.32
Disease-state	Fr. III T	TGF-beta signaling pathway	0.031	0.35
Disease-state	Fr. III T	Estrogen signaling pathway	0.032	0.35
Disease-state	Fr. III T	Lipid and atherosclerosis	0.033	0.35
Disease-state	Fr. III T	Kaposi sarcoma-associated herpesvirus infection	0.035	0.36
Disease-state	Fr. III T	Growth hormone synthesis, secretion and action	0.037	0.36
Disease-state	Fr. III T	Glycolysis / Gluconeogenesis	0.037	0.36
Disease-state	Fr. III T	Signaling pathways regulating pluripotency of stem cells	0.043	0.4
Disease-state	Fr. III T	Toxoplasmosis	0.049	0.45
Disease-state	Naive CD8	Proteasome	6.6e-10	2.1e-07
Disease-state	Naive CD8	Influenza A	1.1e-08	1.8e-06
Disease-state	Naive CD8	Measles	6.1e-07	6.5e-05
Disease-state	Naive CD8	Epstein-Barr virus infection	1.5e-06	0.00012
Disease-state	Naive CD8	Human immunodeficiency virus 1 infection	3.8e-06	0.00023
Disease-state	Naive CD8	Hepatitis C	4.2e-06	0.00023
Disease-state	Naive CD8	Shigellosis	2.3e-05	0.0011
Disease-state	Naive CD8	Necroptosis	9.3e-05	0.0037
Disease-state	Naive CD8	Parkinson disease	0.00012	0.0043
Disease-state	Naive CD8	NOD-like receptor signaling pathway	0.00013	0.0043
Disease-state	Naive CD8	Antigen processing and presentation	0.0002	0.0059
Disease-state	Naive CD8	Inflammatory bowel disease	0.00053	0.014
Disease-state	Naive CD8	RIG-I-like receptor signaling pathway	0.00066	0.016
Disease-state	Naive CD8	Hepatitis B	0.00072	0.016
Disease-state	Naive CD8	JAK-STAT signaling pathway	0.00086	0.018
Disease-state	Naive CD8	Herpes simplex virus 1 infection	0.00089	0.018
Disease-state	Naive CD8	Amyotrophic lateral sclerosis	0.0017	0.031
Disease-state	Naive CD8	Pathways of neurodegeneration - multiple diseases	0.0018	0.031
Disease-state	Naive CD8	Spinocerebellar ataxia	0.0019	0.032
Disease-state	Naive CD8	Toxoplasmosis	0.0021	0.033
Disease-state	Naive CD8	Insulin signaling pathway	0.0023	0.035
Disease-state	Naive CD8	Insulin resistance	0.0038	0.055
Disease-state	Naive CD8	Citrate cycle (TCA cycle)	0.0045	0.063
Disease-state	Naive CD8	Prolactin signaling pathway	0.0051	0.068
Disease-state	Naive CD8	Regulation of actin cytoskeleton	0.0076	0.098
Disease-state	Naive CD8	Human cytomegalovirus infection	0.0079	0.098
Disease-state	Naive CD8	Salmonella infection	0.0083	0.098
Disease-state	Naive CD8	Growth hormone synthesis, secretion and action	0.0089	0.099
Disease-state	Naive CD8	Apoptosis - multiple species	0.0089	0.099
Disease-state	Naive CD8	Neurotrophin signaling pathway	0.0093	0.099
Disease-state	Naive CD8	Yersinia infection	0.011	0.11
Disease-state	Naive CD8	Alzheimer disease	0.011	0.11
Disease-state	Naive CD8	TNF signaling pathway	0.012	0.12
Disease-state	Naive CD8	Apoptosis	0.014	0.13
Disease-state	Naive CD8	Central carbon metabolism in cancer	0.014	0.13
Disease-state	Naive CD8	Tuberculosis	0.015	0.13
Disease-state	Naive CD8	Protein processing in endoplasmic reticulum	0.016	0.14
Disease-state	Naive CD8	Bacterial invasion of epithelial cells	0.018	0.15
Disease-state	Naive CD8	Acute myeloid leukemia	0.018	0.15
Disease-state	Naive CD8	Leukocyte transendothelial migration	0.019	0.15
Disease-state	Naive CD8	Huntington disease	0.02	0.16
Disease-state	Naive CD8	Prion disease	0.021	0.16
Disease-state	Naive CD8	Sphingolipid signaling pathway	0.022	0.16
Disease-state	Naive CD8	Cytosolic DNA-sensing pathway	0.023	0.16
Disease-state	Naive CD8	Lipid and atherosclerosis	0.023	0.16
Disease-state	Naive CD8	Adipocytokine signaling pathway	0.024	0.16
Disease-state	Naive CD8	Th17 cell differentiation	0.026	0.18
Disease-state	Naive CD8	C-type lectin receptor signaling pathway	0.03	0.19
Disease-state	Naive CD8	Th1 and Th2 cell differentiation	0.03	0.19
Disease-state	Naive CD8	Chronic myeloid leukemia	0.03	0.19
Disease-state	Naive CD8	Cellular senescence	0.038	0.24
Disease-state	Naive CD8	FoxO signaling pathway	0.041	0.25
Disease-state	Naive CD8	NF-kappa B signaling pathway	0.044	0.27
Disease-state	CM CD8	Influenza A	1.6e-07	4.5e-05
Disease-state	CM CD8	Hepatitis C	6.7e-07	6.5e-05
Disease-state	CM CD8	Measles	6.7e-07	6.5e-05
Disease-state	CM CD8	Proteasome	1.5e-05	0.0011
Disease-state	CM CD8	JAK-STAT signaling pathway	7e-05	0.0041
Disease-state	CM CD8	Epstein-Barr virus infection	0.00019	0.0091
Disease-state	CM CD8	Toxoplasmosis	0.00043	0.018
Disease-state	CM CD8	NOD-like receptor signaling pathway	0.0014	0.05
Disease-state	CM CD8	Necroptosis	0.0019	0.057
Disease-state	CM CD8	HIF-1 signaling pathway	0.002	0.057
Disease-state	CM CD8	Glycolysis / Gluconeogenesis	0.0024	0.062
Disease-state	CM CD8	Prolactin signaling pathway	0.0025	0.062
Disease-state	CM CD8	Antigen processing and presentation	0.0029	0.066
Disease-state	CM CD8	Parkinson disease	0.0049	0.1
Disease-state	CM CD8	Fructose and mannose metabolism	0.0063	0.12
Disease-state	CM CD8	Type II diabetes mellitus	0.0063	0.12
Disease-state	CM CD8	Chronic myeloid leukemia	0.0078	0.13
Disease-state	CM CD8	Cytokine-cytokine receptor interaction	0.0086	0.13
Disease-state	CM CD8	Central carbon metabolism in cancer	0.0091	0.13
Disease-state	CM CD8	Viral carcinogenesis	0.0092	0.13
Disease-state	CM CD8	Lipid and atherosclerosis	0.0092	0.13
Disease-state	CM CD8	Kaposi sarcoma-associated herpesvirus infection	0.011	0.14
Disease-state	CM CD8	Thyroid cancer	0.011	0.14
Disease-state	CM CD8	TGF-beta signaling pathway	0.012	0.14
Disease-state	CM CD8	PI3K-Akt signaling pathway	0.015	0.18
Disease-state	CM CD8	Pancreatic cancer	0.016	0.18
Disease-state	CM CD8	Human cytomegalovirus infection	0.018	0.2
Disease-state	CM CD8	Toll-like receptor signaling pathway	0.021	0.22
Disease-state	CM CD8	Legionellosis	0.022	0.23
Disease-state	CM CD8	Protein processing in endoplasmic reticulum	0.024	0.23
Disease-state	CM CD8	Pathways in cancer	0.025	0.23
Disease-state	CM CD8	Herpes simplex virus 1 infection	0.025	0.23
Disease-state	CM CD8	Human immunodeficiency virus 1 infection	0.027	0.23
Disease-state	CM CD8	Biosynthesis of amino acids	0.028	0.23
Disease-state	CM CD8	Th17 cell differentiation	0.028	0.23
Disease-state	CM CD8	Chemical carcinogenesis - receptor activation	0.028	0.23
Disease-state	CM CD8	Human T-cell leukemia virus 1 infection	0.029	0.23
Disease-state	CM CD8	Parathyroid hormone synthesis, secretion and action	0.034	0.26
Disease-state	CM CD8	Coronavirus disease - COVID-19	0.035	0.26
Disease-state	CM CD8	Hepatitis B	0.035	0.26
Disease-state	CM CD8	Shigellosis	0.038	0.27
Disease-state	CM CD8	Cell cycle	0.039	0.27
Disease-state	CM CD8	Acute myeloid leukemia	0.041	0.28
Disease-state	CM CD8	Bladder cancer	0.042	0.28
Disease-state	CM CD8	NF-kappa B signaling pathway	0.043	0.28
Disease-state	CM CD8	Biosynthesis of nucleotide sugars	0.047	0.3
Disease-state	EM CD8	Parkinson disease	1.6e-18	5e-16
Disease-state	EM CD8	Proteasome	2.2e-16	3.5e-14
Disease-state	EM CD8	Pathways of neurodegeneration - multiple diseases	3.6e-14	3.9e-12
Disease-state	EM CD8	Alzheimer disease	1.2e-13	9.9e-12
Disease-state	EM CD8	Prion disease	1.5e-13	9.9e-12
Disease-state	EM CD8	Oxidative phosphorylation	1.7e-10	8.9e-09
Disease-state	EM CD8	Amyotrophic lateral sclerosis	1.9e-10	8.9e-09
Disease-state	EM CD8	Epstein-Barr virus infection	2.5e-10	9.9e-09
Disease-state	EM CD8	Huntington disease	2.8e-10	9.9e-09
Disease-state	EM CD8	Chemical carcinogenesis - reactive oxygen species	1.2e-08	3.8e-07
Disease-state	EM CD8	Influenza A	4e-08	1.2e-06
Disease-state	EM CD8	Diabetic cardiomyopathy	5.7e-08	1.5e-06
Disease-state	EM CD8	Thermogenesis	2.4e-07	6e-06
Disease-state	EM CD8	Spinocerebellar ataxia	3e-07	6.4e-06
Disease-state	EM CD8	Non-alcoholic fatty liver disease	3e-07	6.4e-06
Disease-state	EM CD8	Rap1 signaling pathway	3.4e-06	6.8e-05
Disease-state	EM CD8	Salmonella infection	8.2e-06	0.00015
Disease-state	EM CD8	Th17 cell differentiation	9.8e-06	0.00018
Disease-state	EM CD8	Measles	6e-05	0.001
Disease-state	EM CD8	Cardiac muscle contraction	8.6e-05	0.0014
Disease-state	EM CD8	Neurotrophin signaling pathway	9.7e-05	0.0015
Disease-state	EM CD8	Th1 and Th2 cell differentiation	0.00011	0.0016
Disease-state	EM CD8	Antigen processing and presentation	0.00013	0.0018
Disease-state	EM CD8	Regulation of actin cytoskeleton	0.00025	0.0034
Disease-state	EM CD8	Glioma	0.00029	0.0038
Disease-state	EM CD8	NOD-like receptor signaling pathway	0.00031	0.0038
Disease-state	EM CD8	Inflammatory bowel disease	0.00032	0.0038
Disease-state	EM CD8	Long-term potentiation	0.00042	0.0048
Disease-state	EM CD8	Necroptosis	0.00044	0.0048
Disease-state	EM CD8	Shigellosis	0.00044	0.0048
Disease-state	EM CD8	Human immunodeficiency virus 1 infection	0.00068	0.0069
Disease-state	EM CD8	Amphetamine addiction	0.00068	0.0069
Disease-state	EM CD8	Leukocyte transendothelial migration	0.00075	0.0073
Disease-state	EM CD8	Toxoplasmosis	0.00088	0.0083
Disease-state	EM CD8	PD-L1 expression and PD-1 checkpoint pathway in cancer	0.00096	0.0088
Disease-state	EM CD8	Herpes simplex virus 1 infection	0.001	0.0091
Disease-state	EM CD8	Viral myocarditis	0.0011	0.0092
Disease-state	EM CD8	Natural killer cell mediated cytotoxicity	0.0016	0.013
Disease-state	EM CD8	Chemokine signaling pathway	0.0019	0.015
Disease-state	EM CD8	Steroid biosynthesis	0.0026	0.021
Disease-state	EM CD8	Pathogenic Escherichia coli infection	0.003	0.024
Disease-state	EM CD8	Pancreatic secretion	0.0031	0.024
Disease-state	EM CD8	JAK-STAT signaling pathway	0.0032	0.024
Disease-state	EM CD8	Human cytomegalovirus infection	0.0036	0.027
Disease-state	EM CD8	cAMP signaling pathway	0.0044	0.031
Disease-state	EM CD8	Apoptosis	0.0045	0.031
Disease-state	EM CD8	Pathways in cancer	0.0046	0.031
Disease-state	EM CD8	Oxytocin signaling pathway	0.0046	0.031
Disease-state	EM CD8	Bacterial invasion of epithelial cells	0.0058	0.038
Disease-state	EM CD8	GABAergic synapse	0.0077	0.049
Disease-state	EM CD8	Hepatitis C	0.0079	0.05
Disease-state	EM CD8	T cell receptor signaling pathway	0.0092	0.057
Disease-state	EM CD8	Central carbon metabolism in cancer	0.0094	0.057
Disease-state	EM CD8	Tuberculosis	0.0097	0.058
Disease-state	EM CD8	Rheumatoid arthritis	0.01	0.059
Disease-state	EM CD8	Retrograde endocannabinoid signaling	0.01	0.06
Disease-state	EM CD8	Lipid and atherosclerosis	0.011	0.062
Disease-state	EM CD8	Fc gamma R-mediated phagocytosis	0.012	0.064
Disease-state	EM CD8	Gastric acid secretion	0.013	0.069
Disease-state	EM CD8	Human T-cell leukemia virus 1 infection	0.013	0.069
Disease-state	EM CD8	MAPK signaling pathway	0.014	0.069
Disease-state	EM CD8	Tight junction	0.014	0.069
Disease-state	EM CD8	Autoimmune thyroid disease	0.014	0.069
Disease-state	EM CD8	Allograft rejection	0.014	0.069
Disease-state	EM CD8	Graft-versus-host disease	0.014	0.069
Disease-state	EM CD8	Primary immunodeficiency	0.014	0.069
Disease-state	EM CD8	Asthma	0.015	0.074
Disease-state	EM CD8	Proximal tubule bicarbonate reclamation	0.017	0.078
Disease-state	EM CD8	Pancreatic cancer	0.017	0.078
Disease-state	EM CD8	Viral carcinogenesis	0.017	0.08
Disease-state	EM CD8	Yersinia infection	0.018	0.082
Disease-state	EM CD8	Non-small cell lung cancer	0.018	0.082
Disease-state	EM CD8	Leishmaniasis	0.023	0.1
Disease-state	EM CD8	Type I diabetes mellitus	0.024	0.1
Disease-state	EM CD8	Kaposi sarcoma-associated herpesvirus infection	0.027	0.12
Disease-state	EM CD8	Circadian entrainment	0.029	0.12
Disease-state	EM CD8	Adrenergic signaling in cardiomyocytes	0.029	0.12
Disease-state	EM CD8	Aldosterone synthesis and secretion	0.03	0.12
Disease-state	EM CD8	VEGF signaling pathway	0.03	0.12
Disease-state	EM CD8	MicroRNAs in cancer	0.032	0.13
Disease-state	EM CD8	Dopaminergic synapse	0.034	0.13
Disease-state	EM CD8	Melanoma	0.037	0.14
Disease-state	EM CD8	GnRH signaling pathway	0.041	0.16
Disease-state	EM CD8	Inflammatory mediator regulation of TRP channels	0.042	0.16
Disease-state	EM CD8	Bladder cancer	0.043	0.16
Disease-state	EM CD8	Circadian rhythm	0.046	0.17
Disease-state	TEMRA CD8	Measles	4.7e-07	0.00014
Disease-state	TEMRA CD8	Influenza A	3.3e-06	0.00041
Disease-state	TEMRA CD8	NOD-like receptor signaling pathway	4.2e-06	0.00041
Disease-state	TEMRA CD8	Parkinson disease	1.2e-05	0.00089
Disease-state	TEMRA CD8	Epstein-Barr virus infection	1.6e-05	0.00095
Disease-state	TEMRA CD8	Hepatitis C	2.7e-05	0.0013
Disease-state	TEMRA CD8	Necroptosis	3.4e-05	0.0014
Disease-state	TEMRA CD8	JAK-STAT signaling pathway	0.00014	0.0053
Disease-state	TEMRA CD8	Proteasome	0.00059	0.019
Disease-state	TEMRA CD8	Human T-cell leukemia virus 1 infection	0.0015	0.044
Disease-state	TEMRA CD8	RIG-I-like receptor signaling pathway	0.0018	0.045
Disease-state	TEMRA CD8	Prion disease	0.0018	0.045
Disease-state	TEMRA CD8	Pathways of neurodegeneration - multiple diseases	0.0023	0.052
Disease-state	TEMRA CD8	Steroid biosynthesis	0.0032	0.065
Disease-state	TEMRA CD8	Alzheimer disease	0.0035	0.065
Disease-state	TEMRA CD8	Kaposi sarcoma-associated herpesvirus infection	0.0035	0.065
Disease-state	TEMRA CD8	Cardiac muscle contraction	0.004	0.07
Disease-state	TEMRA CD8	Oxidative phosphorylation	0.0045	0.074
Disease-state	TEMRA CD8	Pancreatic cancer	0.0051	0.077
Disease-state	TEMRA CD8	Human cytomegalovirus infection	0.0052	0.077
Disease-state	TEMRA CD8	Coronavirus disease - COVID-19	0.0055	0.078
Disease-state	TEMRA CD8	Th17 cell differentiation	0.0062	0.083
Disease-state	TEMRA CD8	EGFR tyrosine kinase inhibitor resistance	0.007	0.086
Disease-state	TEMRA CD8	Chemical carcinogenesis - reactive oxygen species	0.0071	0.086
Disease-state	TEMRA CD8	Huntington disease	0.0073	0.086
Disease-state	TEMRA CD8	Neurotrophin signaling pathway	0.0093	0.11
Disease-state	TEMRA CD8	PPAR signaling pathway	0.01	0.11
Disease-state	TEMRA CD8	Hepatitis B	0.01	0.11
Disease-state	TEMRA CD8	Amyotrophic lateral sclerosis	0.011	0.11
Disease-state	TEMRA CD8	Ovarian steroidogenesis	0.011	0.11
Disease-state	TEMRA CD8	Diabetic cardiomyopathy	0.012	0.11
Disease-state	TEMRA CD8	Cytosolic DNA-sensing pathway	0.015	0.13
Disease-state	TEMRA CD8	Spinocerebellar ataxia	0.019	0.17
Disease-state	TEMRA CD8	Fatty acid metabolism	0.02	0.17
Disease-state	TEMRA CD8	Apoptosis - multiple species	0.021	0.17
Disease-state	TEMRA CD8	Toxoplasmosis	0.021	0.17
Disease-state	TEMRA CD8	AGE-RAGE signaling pathway in diabetic complications	0.025	0.19
Disease-state	TEMRA CD8	Antigen processing and presentation	0.025	0.19
Disease-state	TEMRA CD8	Viral carcinogenesis	0.026	0.19
Disease-state	TEMRA CD8	Glycosaminoglycan biosynthesis - keratan sulfate	0.026	0.19
Disease-state	TEMRA CD8	Endocrine resistance	0.029	0.2
Disease-state	TEMRA CD8	Parathyroid hormone synthesis, secretion and action	0.029	0.2
Disease-state	TEMRA CD8	PI3K-Akt signaling pathway	0.03	0.21
Disease-state	TEMRA CD8	Prolactin signaling pathway	0.032	0.21
Disease-state	TEMRA CD8	Th1 and Th2 cell differentiation	0.033	0.22
Disease-state	TEMRA CD8	Human immunodeficiency virus 1 infection	0.036	0.23
Disease-state	TEMRA CD8	Galactose metabolism	0.036	0.23
Disease-state	TEMRA CD8	Gap junction	0.038	0.23
Disease-state	TEMRA CD8	Bladder cancer	0.039	0.23
Disease-state	TEMRA CD8	Choline metabolism in cancer	0.04	0.24
Disease-state	TEMRA CD8	Thermogenesis	0.043	0.25
Disease-state	TEMRA CD8	Insulin signaling pathway	0.045	0.25
Disease-state	TEMRA CD8	Glycolysis / Gluconeogenesis	0.045	0.25
Disease-state	TEMRA CD8	Signaling pathways regulating pluripotency of stem cells	0.046	0.25
Disease-state	TEMRA CD8	Olfactory transduction	0.048	0.26
Disease-state	TEMRA CD8	Oocyte meiosis	0.049	0.26
Disease-state	TEMRA CD8	Lipid and atherosclerosis	0.05	0.26
Disease-state	NK	Proteasome	2.7e-17	8.9e-15
Disease-state	NK	Parkinson disease	2.4e-15	3.9e-13
Disease-state	NK	Prion disease	6.9e-11	7.5e-09
Disease-state	NK	Oxidative phosphorylation	1.1e-09	8.7e-08
Disease-state	NK	Huntington disease	3.6e-09	2.3e-07
Disease-state	NK	Amyotrophic lateral sclerosis	6e-09	3.1e-07
Disease-state	NK	Diabetic cardiomyopathy	6.7e-09	3.1e-07
Disease-state	NK	Spinocerebellar ataxia	7.6e-09	3.1e-07
Disease-state	NK	Thermogenesis	5.2e-07	1.9e-05
Disease-state	NK	Pathways of neurodegeneration - multiple diseases	6.6e-07	2.1e-05
Disease-state	NK	Alzheimer disease	7.4e-07	2.2e-05
Disease-state	NK	Epstein-Barr virus infection	8.9e-07	2.3e-05
Disease-state	NK	Cell cycle	9.4e-07	2.3e-05
Disease-state	NK	Cellular senescence	1.1e-05	0.00025
Disease-state	NK	Chemical carcinogenesis - reactive oxygen species	3e-05	0.00065
Disease-state	NK	Influenza A	4e-05	0.00082
Disease-state	NK	Th17 cell differentiation	0.00028	0.0054
Disease-state	NK	Antigen processing and presentation	0.00045	0.0081
Disease-state	NK	Non-alcoholic fatty liver disease	0.00068	0.012
Disease-state	NK	Human T-cell leukemia virus 1 infection	0.0013	0.022
Disease-state	NK	Necroptosis	0.0015	0.023
Disease-state	NK	Biosynthesis of amino acids	0.0019	0.027
Disease-state	NK	Inflammatory bowel disease	0.0019	0.027
Disease-state	NK	JAK-STAT signaling pathway	0.003	0.039
Disease-state	NK	Circadian rhythm	0.003	0.039
Disease-state	NK	Metabolic pathways	0.0031	0.039
Disease-state	NK	Platinum drug resistance	0.0034	0.04
Disease-state	NK	Central carbon metabolism in cancer	0.0034	0.04
Disease-state	NK	Hepatitis C	0.0035	0.04
Disease-state	NK	Hepatitis B	0.0064	0.07
Disease-state	NK	p53 signaling pathway	0.007	0.073
Disease-state	NK	Glycolysis / Gluconeogenesis	0.008	0.081
Disease-state	NK	Herpes simplex virus 1 infection	0.0088	0.087
Disease-state	NK	Human immunodeficiency virus 1 infection	0.01	0.096
Disease-state	NK	Th1 and Th2 cell differentiation	0.012	0.11
Disease-state	NK	Longevity regulating pathway	0.016	0.14
Disease-state	NK	Progesterone-mediated oocyte maturation	0.016	0.14
Disease-state	NK	Fatty acid metabolism	0.017	0.15
Disease-state	NK	Cardiac muscle contraction	0.018	0.15
Disease-state	NK	Toxoplasmosis	0.018	0.15
Disease-state	NK	Glioma	0.019	0.15
Disease-state	NK	Apoptosis	0.02	0.15
Disease-state	NK	Pancreatic cancer	0.021	0.15
Disease-state	NK	Choline metabolism in cancer	0.021	0.15
Disease-state	NK	Colorectal cancer	0.023	0.16
Disease-state	NK	Human cytomegalovirus infection	0.025	0.17
Disease-state	NK	Protein processing in endoplasmic reticulum	0.027	0.19
Disease-state	NK	Measles	0.029	0.2
Disease-state	NK	Oocyte meiosis	0.031	0.21
Disease-state	NK	Steroid biosynthesis	0.033	0.21
Disease-state	NK	NOD-like receptor signaling pathway	0.036	0.23
Disease-state	NK	Carbon metabolism	0.038	0.24
Disease-state	NK	Vibrio cholerae infection	0.04	0.24
Disease-state	NK	Viral myocarditis	0.043	0.26
Disease-state	NK	Parathyroid hormone synthesis, secretion and action	0.046	0.26
Disease-state	NK	Asthma	0.046	0.26
Disease-state	NK	Biosynthesis of unsaturated fatty acids	0.046	0.26
Disease-state	NK	Lipid and atherosclerosis	0.05	0.28
Disease-state	Naive B	Parkinson disease	8.3e-16	2.7e-13
Disease-state	Naive B	Oxidative phosphorylation	1.2e-14	2e-12
Disease-state	Naive B	Prion disease	6.7e-13	7.2e-11
Disease-state	Naive B	Huntington disease	8e-12	6.5e-10
Disease-state	Naive B	Chemical carcinogenesis - reactive oxygen species	1.8e-10	1.2e-08
Disease-state	Naive B	Diabetic cardiomyopathy	1.8e-09	9.4e-08
Disease-state	Naive B	Pathways of neurodegeneration - multiple diseases	2e-09	9.4e-08
Disease-state	Naive B	Proteasome	5.9e-09	2.4e-07
Disease-state	Naive B	Alzheimer disease	2e-08	7e-07
Disease-state	Naive B	Amyotrophic lateral sclerosis	6.8e-08	2.2e-06
Disease-state	Naive B	Epstein-Barr virus infection	2.4e-07	6.9e-06
Disease-state	Naive B	Non-alcoholic fatty liver disease	3.4e-06	8.4e-05
Disease-state	Naive B	Influenza A	3.4e-06	8.4e-05
Disease-state	Naive B	Measles	9.6e-06	0.00022
Disease-state	Naive B	Hepatitis C	2.2e-05	0.00048
Disease-state	Naive B	Thermogenesis	4.9e-05	0.00099
Disease-state	Naive B	NOD-like receptor signaling pathway	6.2e-05	0.0012
Disease-state	Naive B	Shigellosis	0.0003	0.0055
Disease-state	Naive B	Glycolysis / Gluconeogenesis	0.00082	0.014
Disease-state	Naive B	Antigen processing and presentation	0.00093	0.015
Disease-state	Naive B	Metabolic pathways	0.001	0.016
Disease-state	Naive B	Spinocerebellar ataxia	0.0012	0.017
Disease-state	Naive B	Kaposi sarcoma-associated herpesvirus infection	0.0015	0.02
Disease-state	Naive B	Herpes simplex virus 1 infection	0.0032	0.043
Disease-state	Naive B	Carbon metabolism	0.0041	0.054
Disease-state	Naive B	Necroptosis	0.0044	0.054
Disease-state	Naive B	Cardiac muscle contraction	0.0053	0.063
Disease-state	Naive B	Salmonella infection	0.0055	0.064
Disease-state	Naive B	Tuberculosis	0.0058	0.065
Disease-state	Naive B	JAK-STAT signaling pathway	0.007	0.076
Disease-state	Naive B	Sphingolipid metabolism	0.008	0.084
Disease-state	Naive B	Hepatitis B	0.01	0.1
Disease-state	Naive B	Protein processing in endoplasmic reticulum	0.011	0.1
Disease-state	Naive B	Cytosolic DNA-sensing pathway	0.012	0.11
Disease-state	Naive B	Mucin type O-glycan biosynthesis	0.013	0.12
Disease-state	Naive B	Bacterial invasion of epithelial cells	0.017	0.15
Disease-state	Naive B	Steroid biosynthesis	0.018	0.15
Disease-state	Naive B	RIG-I-like receptor signaling pathway	0.018	0.15
Disease-state	Naive B	Fc gamma R-mediated phagocytosis	0.02	0.17
Disease-state	Naive B	Human cytomegalovirus infection	0.021	0.17
Disease-state	Naive B	HIF-1 signaling pathway	0.021	0.17
Disease-state	Naive B	Lipid and atherosclerosis	0.022	0.17
Disease-state	Naive B	Biosynthesis of amino acids	0.022	0.17
Disease-state	Naive B	Retrograde endocannabinoid signaling	0.027	0.2
Disease-state	Naive B	Glucagon signaling pathway	0.03	0.21
Disease-state	Naive B	Glyoxylate and dicarboxylate metabolism	0.031	0.21
Disease-state	Naive B	Human papillomavirus infection	0.031	0.21
Disease-state	Naive B	Fructose and mannose metabolism	0.031	0.21
Disease-state	Naive B	Regulation of actin cytoskeleton	0.033	0.22
Disease-state	Naive B	Lysosome	0.036	0.23
Disease-state	Naive B	Yersinia infection	0.037	0.24
Disease-state	Naive B	Vibrio cholerae infection	0.04	0.25
Disease-state	Naive B	Cellular senescence	0.042	0.26
Disease-state	Naive B	Leishmaniasis	0.044	0.26
Disease-state	Naive B	Coronavirus disease - COVID-19	0.049	0.29
Disease-state	Naive B	Toxoplasmosis	0.05	0.29
Disease-state	USM B	Parkinson disease	1.2e-21	3.9e-19
Disease-state	USM B	Oxidative phosphorylation	1.4e-20	2.3e-18
Disease-state	USM B	Prion disease	2.8e-18	3.1e-16
Disease-state	USM B	Amyotrophic lateral sclerosis	6e-16	4.8e-14
Disease-state	USM B	Diabetic cardiomyopathy	5.5e-15	3.6e-13
Disease-state	USM B	Alzheimer disease	1.2e-13	6.3e-12
Disease-state	USM B	Pathways of neurodegeneration - multiple diseases	5.3e-13	2.5e-11
Disease-state	USM B	Huntington disease	5.6e-12	2.3e-10
Disease-state	USM B	Proteasome	7e-12	2.5e-10
Disease-state	USM B	Thermogenesis	7.6e-11	2.5e-09
Disease-state	USM B	Chemical carcinogenesis - reactive oxygen species	4.5e-10	1.3e-08
Disease-state	USM B	Non-alcoholic fatty liver disease	1.7e-09	4.6e-08
Disease-state	USM B	Protein processing in endoplasmic reticulum	7.7e-07	1.9e-05
Disease-state	USM B	Metabolic pathways	0.00021	0.0049
Disease-state	USM B	Cardiac muscle contraction	0.00057	0.012
Disease-state	USM B	Hepatitis C	0.00066	0.013
Disease-state	USM B	Protein export	0.00068	0.013
Disease-state	USM B	Lysosome	0.00088	0.016
Disease-state	USM B	p53 signaling pathway	0.0012	0.021
Disease-state	USM B	Vibrio cholerae infection	0.0013	0.022
Disease-state	USM B	Herpes simplex virus 1 infection	0.0017	0.026
Disease-state	USM B	Spinocerebellar ataxia	0.0019	0.028
Disease-state	USM B	Retrograde endocannabinoid signaling	0.0044	0.063
Disease-state	USM B	B cell receptor signaling pathway	0.0052	0.07
Disease-state	USM B	Glucagon signaling pathway	0.0071	0.092
Disease-state	USM B	Influenza A	0.0088	0.11
Disease-state	USM B	Porphyrin and chlorophyll metabolism	0.01	0.12
Disease-state	USM B	Neurotrophin signaling pathway	0.012	0.14
Disease-state	USM B	Autophagy - other	0.012	0.14
Disease-state	USM B	N-Glycan biosynthesis	0.019	0.21
Disease-state	USM B	Biosynthesis of nucleotide sugars	0.02	0.21
Disease-state	USM B	Cell cycle	0.022	0.22
Disease-state	USM B	Fat digestion and absorption	0.023	0.22
Disease-state	USM B	Autophagy - animal	0.024	0.23
Disease-state	USM B	Other glycan degradation	0.025	0.23
Disease-state	USM B	Various types of N-glycan biosynthesis	0.03	0.27
Disease-state	USM B	Cellular senescence	0.035	0.3
Disease-state	USM B	Human immunodeficiency virus 1 infection	0.036	0.31
Disease-state	USM B	Carbon metabolism	0.043	0.35
Disease-state	USM B	Citrate cycle (TCA cycle)	0.047	0.37
Disease-state	USM B	Glyoxylate and dicarboxylate metabolism	0.047	0.37
Disease-state	SM B	Parkinson disease	1.9e-16	6.2e-14
Disease-state	SM B	Proteasome	1.2e-15	1.9e-13
Disease-state	SM B	Prion disease	3.9e-13	4.2e-11
Disease-state	SM B	Amyotrophic lateral sclerosis	5.3e-13	4.3e-11
Disease-state	SM B	Pathways of neurodegeneration - multiple diseases	8e-13	5.2e-11
Disease-state	SM B	Huntington disease	1.2e-11	6.2e-10
Disease-state	SM B	Oxidative phosphorylation	1.9e-09	8.6e-08
Disease-state	SM B	Alzheimer disease	1.8e-07	7.4e-06
Disease-state	SM B	Protein processing in endoplasmic reticulum	1e-06	3.6e-05
Disease-state	SM B	Epstein-Barr virus infection	1.3e-06	4.1e-05
Disease-state	SM B	Chemical carcinogenesis - reactive oxygen species	1.1e-05	0.0003
Disease-state	SM B	Salmonella infection	1.1e-05	0.0003
Disease-state	SM B	Diabetic cardiomyopathy	1.5e-05	0.00036
Disease-state	SM B	Spinocerebellar ataxia	3.4e-05	0.00078
Disease-state	SM B	Non-alcoholic fatty liver disease	9.3e-05	0.002
Disease-state	SM B	Shigellosis	0.00012	0.0025
Disease-state	SM B	Pathogenic Escherichia coli infection	0.00018	0.0034
Disease-state	SM B	Thermogenesis	0.00039	0.0071
Disease-state	SM B	Hepatitis C	0.00064	0.01
Disease-state	SM B	Measles	0.00064	0.01
Disease-state	SM B	Terpenoid backbone biosynthesis	0.00095	0.015
Disease-state	SM B	Human immunodeficiency virus 1 infection	0.0011	0.017
Disease-state	SM B	Glycolysis / Gluconeogenesis	0.0017	0.024
Disease-state	SM B	Endocytosis	0.0021	0.028
Disease-state	SM B	Tight junction	0.0027	0.035
Disease-state	SM B	Kaposi sarcoma-associated herpesvirus infection	0.0028	0.035
Disease-state	SM B	Vibrio cholerae infection	0.0045	0.053
Disease-state	SM B	Influenza A	0.0046	0.053
Disease-state	SM B	Retrograde endocannabinoid signaling	0.0057	0.063
Disease-state	SM B	Bacterial invasion of epithelial cells	0.0064	0.069
Disease-state	SM B	Steroid biosynthesis	0.0072	0.075
Disease-state	SM B	Cellular senescence	0.0079	0.08
Disease-state	SM B	Apoptosis	0.0084	0.083
Disease-state	SM B	Human cytomegalovirus infection	0.009	0.086
Disease-state	SM B	Pyruvate metabolism	0.012	0.11
Disease-state	SM B	RIG-I-like receptor signaling pathway	0.013	0.11
Disease-state	SM B	Viral carcinogenesis	0.014	0.12
Disease-state	SM B	Lipid and atherosclerosis	0.014	0.12
Disease-state	SM B	NOD-like receptor signaling pathway	0.016	0.13
Disease-state	SM B	B cell receptor signaling pathway	0.018	0.15
Disease-state	SM B	Lysosome	0.02	0.16
Disease-state	SM B	Glucagon signaling pathway	0.022	0.17
Disease-state	SM B	Cardiac muscle contraction	0.023	0.17
Disease-state	SM B	Other glycan degradation	0.023	0.17
Disease-state	SM B	Neurotrophin signaling pathway	0.03	0.21
Disease-state	SM B	Adrenergic signaling in cardiomyocytes	0.03	0.21
Disease-state	SM B	cGMP-PKG signaling pathway	0.034	0.23
Disease-state	SM B	Leukocyte transendothelial migration	0.038	0.26
Disease-state	SM B	Aminoacyl-tRNA biosynthesis	0.04	0.27
Disease-state	SM B	Amphetamine addiction	0.043	0.27
Disease-state	SM B	Hepatitis B	0.043	0.27
Disease-state	SM B	Citrate cycle (TCA cycle)	0.044	0.27
Disease-state	SM B	Antigen processing and presentation	0.045	0.27
Disease-state	SM B	Cytosolic DNA-sensing pathway	0.046	0.28
Disease-state	SM B	p53 signaling pathway	0.049	0.29
Disease-state	DN B	Parkinson disease	1.5e-20	4.8e-18
Disease-state	DN B	Prion disease	1.1e-17	1.8e-15
Disease-state	DN B	Oxidative phosphorylation	7e-15	7.6e-13
Disease-state	DN B	Amyotrophic lateral sclerosis	1.7e-14	1.4e-12
Disease-state	DN B	Huntington disease	5.3e-14	3.5e-12
Disease-state	DN B	Diabetic cardiomyopathy	6.9e-14	3.8e-12
Disease-state	DN B	Proteasome	3.5e-13	1.6e-11
Disease-state	DN B	Pathways of neurodegeneration - multiple diseases	7.5e-13	3e-11
Disease-state	DN B	Alzheimer disease	1.9e-12	6.9e-11
Disease-state	DN B	Chemical carcinogenesis - reactive oxygen species	3.9e-08	1.3e-06
Disease-state	DN B	Thermogenesis	5.3e-07	1.6e-05
Disease-state	DN B	Non-alcoholic fatty liver disease	7.4e-07	2e-05
Disease-state	DN B	Herpes simplex virus 1 infection	4.4e-06	0.00011
Disease-state	DN B	Protein processing in endoplasmic reticulum	3.4e-05	0.0008
Disease-state	DN B	Spinocerebellar ataxia	4.5e-05	0.00098
Disease-state	DN B	Protein export	0.00035	0.0071
Disease-state	DN B	Terpenoid backbone biosynthesis	0.00037	0.0071
Disease-state	DN B	Cellular senescence	0.00097	0.017
Disease-state	DN B	Epstein-Barr virus infection	0.0011	0.018
Disease-state	DN B	Retrograde endocannabinoid signaling	0.0023	0.038
Disease-state	DN B	Glycolysis / Gluconeogenesis	0.0031	0.047
Disease-state	DN B	Valine, leucine and isoleucine degradation	0.0062	0.088
Disease-state	DN B	Carbon metabolism	0.0065	0.088
Disease-state	DN B	Metabolic pathways	0.0067	0.088
Disease-state	DN B	Citrate cycle (TCA cycle)	0.0067	0.088
Disease-state	DN B	Glucagon signaling pathway	0.0096	0.12
Disease-state	DN B	Influenza A	0.011	0.13
Disease-state	DN B	Pancreatic cancer	0.012	0.14
Disease-state	DN B	Vibrio cholerae infection	0.012	0.14
Disease-state	DN B	Biosynthesis of amino acids	0.014	0.15
Disease-state	DN B	Amino sugar and nucleotide sugar metabolism	0.016	0.16
Disease-state	DN B	Cardiac muscle contraction	0.016	0.16
Disease-state	DN B	Tuberculosis	0.016	0.16
Disease-state	DN B	Fatty acid metabolism	0.018	0.16
Disease-state	DN B	Hepatitis C	0.018	0.16
Disease-state	DN B	Measles	0.018	0.16
Disease-state	DN B	Fatty acid degradation	0.019	0.16
Disease-state	DN B	Synaptic vesicle cycle	0.021	0.18
Disease-state	DN B	Pyruvate metabolism	0.021	0.18
Disease-state	DN B	Cysteine and methionine metabolism	0.024	0.2
Disease-state	DN B	Toxoplasmosis	0.028	0.22
Disease-state	DN B	Antigen processing and presentation	0.037	0.29
Disease-state	DN B	Necroptosis	0.038	0.29
Disease-state	DN B	Various types of N-glycan biosynthesis	0.042	0.31
Disease-state	DN B	Non-homologous end-joining	0.045	0.33
Disease-state	DN B	Cell cycle	0.049	0.35
Disease-state	Plasmablast	Influenza A	4.5e-07	7.4e-05
Disease-state	Plasmablast	Hepatitis C	4.9e-07	7.4e-05
Disease-state	Plasmablast	Epstein-Barr virus infection	1.4e-06	0.00014
Disease-state	Plasmablast	Proteasome	4.7e-06	0.00035
Disease-state	Plasmablast	Measles	5.8e-06	0.00035
Disease-state	Plasmablast	Human papillomavirus infection	4.1e-05	0.0021
Disease-state	Plasmablast	NOD-like receptor signaling pathway	0.00048	0.02
Disease-state	Plasmablast	RIG-I-like receptor signaling pathway	0.00055	0.021
Disease-state	Plasmablast	Coronavirus disease - COVID-19	0.0011	0.038
Disease-state	Plasmablast	Viral carcinogenesis	0.002	0.056
Disease-state	Plasmablast	Toxoplasmosis	0.0021	0.056
Disease-state	Plasmablast	JAK-STAT signaling pathway	0.0029	0.072
Disease-state	Plasmablast	Pathways in cancer	0.0032	0.074
Disease-state	Plasmablast	Cytosolic DNA-sensing pathway	0.0035	0.075
Disease-state	Plasmablast	mTOR signaling pathway	0.0041	0.08
Disease-state	Plasmablast	Antigen processing and presentation	0.0044	0.08
Disease-state	Plasmablast	Kaposi sarcoma-associated herpesvirus infection	0.0046	0.08
Disease-state	Plasmablast	Small cell lung cancer	0.0078	0.13
Disease-state	Plasmablast	PI3K-Akt signaling pathway	0.0089	0.14
Disease-state	Plasmablast	Autoimmune thyroid disease	0.014	0.21
Disease-state	Plasmablast	Hepatitis B	0.015	0.21
Disease-state	Plasmablast	Insulin signaling pathway	0.015	0.21
Disease-state	Plasmablast	Necroptosis	0.016	0.21
Disease-state	Plasmablast	Human cytomegalovirus infection	0.017	0.21
Disease-state	Plasmablast	Hippo signaling pathway - multiple species	0.019	0.21
Disease-state	Plasmablast	Th17 cell differentiation	0.019	0.21
Disease-state	Plasmablast	Viral myocarditis	0.019	0.21
Disease-state	Plasmablast	Type I diabetes mellitus	0.019	0.21
Disease-state	Plasmablast	Th1 and Th2 cell differentiation	0.025	0.26
Disease-state	Plasmablast	Focal adhesion	0.027	0.27
Disease-state	Plasmablast	Non-small cell lung cancer	0.028	0.27
Disease-state	Plasmablast	Spinocerebellar ataxia	0.029	0.27
Disease-state	Plasmablast	Prolactin signaling pathway	0.03	0.27
Disease-state	Plasmablast	Chemical carcinogenesis - reactive oxygen species	0.034	0.3
Disease-state	Plasmablast	Pyrimidine metabolism	0.036	0.3
Disease-state	Plasmablast	Inflammatory bowel disease	0.037	0.3
Disease-state	Plasmablast	Endocytosis	0.038	0.3
Disease-state	Plasmablast	HIF-1 signaling pathway	0.041	0.32
Disease-state	Plasmablast	Insulin resistance	0.045	0.33
Disease-state	Plasmablast	Allograft rejection	0.045	0.33
Disease-state	Plasmablast	Graft-versus-host disease	0.045	0.33
Disease-state	Plasmablast	FoxO signaling pathway	0.047	0.33
Disease-state	Plasmablast	Human T-cell leukemia virus 1 infection	0.048	0.33
Disease-state	CL Mono	Proteasome	9.5e-08	3.1e-05
Disease-state	CL Mono	Influenza A	6.3e-07	0.0001
Disease-state	CL Mono	Epstein-Barr virus infection	4e-05	0.0038
Disease-state	CL Mono	Hepatitis C	4.7e-05	0.0038
Disease-state	CL Mono	RIG-I-like receptor signaling pathway	0.00014	0.009
Disease-state	CL Mono	Adipocytokine signaling pathway	0.00045	0.022
Disease-state	CL Mono	NOD-like receptor signaling pathway	0.00048	0.022
Disease-state	CL Mono	Parkinson disease	0.00087	0.035
Disease-state	CL Mono	Alzheimer disease	0.001	0.036
Disease-state	CL Mono	Measles	0.0012	0.037
Disease-state	CL Mono	Coronavirus disease - COVID-19	0.0015	0.043
Disease-state	CL Mono	Pathways in cancer	0.0021	0.057
Disease-state	CL Mono	Kaposi sarcoma-associated herpesvirus infection	0.0024	0.059
Disease-state	CL Mono	Circadian rhythm	0.0032	0.073
Disease-state	CL Mono	Osteoclast differentiation	0.005	0.11
Disease-state	CL Mono	Human immunodeficiency virus 1 infection	0.0076	0.15
Disease-state	CL Mono	p53 signaling pathway	0.0081	0.15
Disease-state	CL Mono	Necroptosis	0.011	0.17
Disease-state	CL Mono	Acute myeloid leukemia	0.011	0.17
Disease-state	CL Mono	FoxO signaling pathway	0.011	0.17
Disease-state	CL Mono	Endocytosis	0.011	0.17
Disease-state	CL Mono	Transcriptional misregulation in cancer	0.012	0.17
Disease-state	CL Mono	Pathways of neurodegeneration - multiple diseases	0.012	0.17
Disease-state	CL Mono	Circadian entrainment	0.015	0.2
Disease-state	CL Mono	Human cytomegalovirus infection	0.018	0.24
Disease-state	CL Mono	Cytosolic DNA-sensing pathway	0.022	0.27
Disease-state	CL Mono	Oxidative phosphorylation	0.023	0.27
Disease-state	CL Mono	PI3K-Akt signaling pathway	0.024	0.27
Disease-state	CL Mono	Shigellosis	0.025	0.27
Disease-state	CL Mono	Alcoholic liver disease	0.025	0.27
Disease-state	CL Mono	Lipid and atherosclerosis	0.027	0.27
Disease-state	CL Mono	Hepatitis B	0.027	0.27
Disease-state	CL Mono	Citrate cycle (TCA cycle)	0.031	0.3
Disease-state	CL Mono	Amyotrophic lateral sclerosis	0.033	0.31
Disease-state	CL Mono	Autophagy - animal	0.036	0.32
Disease-state	CL Mono	PD-L1 expression and PD-1 checkpoint pathway in cancer	0.036	0.32
Disease-state	CL Mono	Apelin signaling pathway	0.039	0.33
Disease-state	CL Mono	Non-alcoholic fatty liver disease	0.039	0.33
Disease-state	CL Mono	Renin secretion	0.044	0.37
Disease-state	CL Mono	Glycolysis / Gluconeogenesis	0.048	0.38
Disease-state	CL Mono	Salmonella infection	0.049	0.38
Disease-state	CD16p Mono	NOD-like receptor signaling pathway	2.3e-09	7.4e-07
Disease-state	CD16p Mono	Influenza A	4.7e-06	0.00074
Disease-state	CD16p Mono	Epstein-Barr virus infection	1e-05	0.0011
Disease-state	CD16p Mono	Coronavirus disease - COVID-19	6.6e-05	0.0052
Disease-state	CD16p Mono	Hepatitis C	0.00017	0.01
Disease-state	CD16p Mono	Toll-like receptor signaling pathway	0.00041	0.022
Disease-state	CD16p Mono	Hepatitis B	0.00086	0.039
Disease-state	CD16p Mono	Bladder cancer	0.001	0.039
Disease-state	CD16p Mono	Kaposi sarcoma-associated herpesvirus infection	0.0011	0.039
Disease-state	CD16p Mono	Lipid and atherosclerosis	0.0016	0.05
Disease-state	CD16p Mono	Leishmaniasis	0.0024	0.066
Disease-state	CD16p Mono	Lysosome	0.0026	0.066
Disease-state	CD16p Mono	PD-L1 expression and PD-1 checkpoint pathway in cancer	0.0027	0.066
Disease-state	CD16p Mono	RIG-I-like receptor signaling pathway	0.0032	0.071
Disease-state	CD16p Mono	Proteasome	0.0049	0.1
Disease-state	CD16p Mono	Sphingolipid metabolism	0.0059	0.11
Disease-state	CD16p Mono	Complement and coagulation cascades	0.0061	0.11
Disease-state	CD16p Mono	Other glycan degradation	0.0065	0.11
Disease-state	CD16p Mono	Measles	0.0068	0.11
Disease-state	CD16p Mono	Transcriptional misregulation in cancer	0.008	0.12
Disease-state	CD16p Mono	Choline metabolism in cancer	0.0081	0.12
Disease-state	CD16p Mono	Pertussis	0.009	0.13
Disease-state	CD16p Mono	Chemokine signaling pathway	0.0093	0.13
Disease-state	CD16p Mono	Glycosaminoglycan degradation	0.0096	0.13
Disease-state	CD16p Mono	Neuroactive ligand-receptor interaction	0.013	0.16
Disease-state	CD16p Mono	Staphylococcus aureus infection	0.014	0.16
Disease-state	CD16p Mono	Phagosome	0.014	0.16
Disease-state	CD16p Mono	Human cytomegalovirus infection	0.015	0.17
Disease-state	CD16p Mono	Circadian rhythm	0.016	0.18
Disease-state	CD16p Mono	Legionellosis	0.017	0.18
Disease-state	CD16p Mono	Human immunodeficiency virus 1 infection	0.017	0.18
Disease-state	CD16p Mono	Steroid biosynthesis	0.019	0.19
Disease-state	CD16p Mono	JAK-STAT signaling pathway	0.02	0.19
Disease-state	CD16p Mono	EGFR tyrosine kinase inhibitor resistance	0.023	0.22
Disease-state	CD16p Mono	Oxytocin signaling pathway	0.025	0.23
Disease-state	CD16p Mono	Autophagy - animal	0.029	0.25
Disease-state	CD16p Mono	MicroRNAs in cancer	0.029	0.25
Disease-state	CD16p Mono	Antigen processing and presentation	0.031	0.26
Disease-state	CD16p Mono	IL-17 signaling pathway	0.035	0.28
Disease-state	CD16p Mono	Sphingolipid signaling pathway	0.035	0.28
Disease-state	CD16p Mono	Prolactin signaling pathway	0.036	0.28
Disease-state	CD16p Mono	B cell receptor signaling pathway	0.038	0.29
Disease-state	CD16p Mono	Viral protein interaction with cytokine and cytokine receptor	0.04	0.3
Disease-state	CD16p Mono	Protein export	0.042	0.3
Disease-state	CD16p Mono	Toxoplasmosis	0.045	0.32
Disease-state	CD16p Mono	Parathyroid hormone synthesis, secretion and action	0.048	0.33
Disease-state	CD16p Mono	Amino sugar and nucleotide sugar metabolism	0.049	0.33
Disease-state	Int Mono	Epstein-Barr virus infection	4.6e-08	9.6e-06
Disease-state	Int Mono	Coronavirus disease - COVID-19	6.3e-08	9.6e-06
Disease-state	Int Mono	NOD-like receptor signaling pathway	1.4e-07	1.4e-05
Disease-state	Int Mono	Influenza A	5.9e-07	4.5e-05
Disease-state	Int Mono	Hepatitis C	5.6e-06	0.00034
Disease-state	Int Mono	Malaria	0.00039	0.02
Disease-state	Int Mono	Kaposi sarcoma-associated herpesvirus infection	0.00055	0.024
Disease-state	Int Mono	JAK-STAT signaling pathway	0.00072	0.027
Disease-state	Int Mono	Measles	0.00092	0.031
Disease-state	Int Mono	Hepatitis B	0.0015	0.045
Disease-state	Int Mono	Neuroactive ligand-receptor interaction	0.0017	0.047
Disease-state	Int Mono	Viral protein interaction with cytokine and cytokine receptor	0.002	0.049
Disease-state	Int Mono	Circadian rhythm	0.0021	0.049
Disease-state	Int Mono	Bladder cancer	0.0026	0.054
Disease-state	Int Mono	Cytosolic DNA-sensing pathway	0.0027	0.054
Disease-state	Int Mono	Staphylococcus aureus infection	0.0038	0.072
Disease-state	Int Mono	Cytokine-cytokine receptor interaction	0.0047	0.084
Disease-state	Int Mono	Complement and coagulation cascades	0.0061	0.1
Disease-state	Int Mono	Toll-like receptor signaling pathway	0.0064	0.1
Disease-state	Int Mono	Legionellosis	0.0095	0.14
Disease-state	Int Mono	Pathways in cancer	0.012	0.17
Disease-state	Int Mono	MicroRNAs in cancer	0.013	0.17
Disease-state	Int Mono	RIG-I-like receptor signaling pathway	0.015	0.19
Disease-state	Int Mono	Proteasome	0.016	0.19
Disease-state	Int Mono	Human immunodeficiency virus 1 infection	0.016	0.19
Disease-state	Int Mono	Toxoplasmosis	0.016	0.19
Disease-state	Int Mono	Leishmaniasis	0.018	0.21
Disease-state	Int Mono	Pertussis	0.02	0.21
Disease-state	Int Mono	Acute myeloid leukemia	0.02	0.21
Disease-state	Int Mono	Human cytomegalovirus infection	0.021	0.21
Disease-state	Int Mono	PD-L1 expression and PD-1 checkpoint pathway in cancer	0.023	0.22
Disease-state	Int Mono	Steroid biosynthesis	0.024	0.22
Disease-state	Int Mono	Alcoholic liver disease	0.025	0.22
Disease-state	Int Mono	Chemokine signaling pathway	0.026	0.22
Disease-state	Int Mono	Autoimmune thyroid disease	0.026	0.22
Disease-state	Int Mono	Allograft rejection	0.026	0.22
Disease-state	Int Mono	Antigen processing and presentation	0.028	0.23
Disease-state	Int Mono	C-type lectin receptor signaling pathway	0.038	0.29
Disease-state	Int Mono	Transcriptional misregulation in cancer	0.038	0.29
Disease-state	Int Mono	Adipocytokine signaling pathway	0.039	0.29
Disease-state	Int Mono	Glioma	0.043	0.32
Disease-state	Int Mono	Necroptosis	0.046	0.33
Disease-state	NC Mono	Epstein-Barr virus infection	4.9e-10	1.5e-07
Disease-state	NC Mono	NOD-like receptor signaling pathway	1.1e-09	1.7e-07
Disease-state	NC Mono	Influenza A	2.2e-07	2.2e-05
Disease-state	NC Mono	Coronavirus disease - COVID-19	5.1e-06	0.00039
Disease-state	NC Mono	Hepatitis C	6.5e-06	0.00039
Disease-state	NC Mono	Human immunodeficiency virus 1 infection	1.8e-05	0.00085
Disease-state	NC Mono	Measles	2e-05	0.00085
Disease-state	NC Mono	Hepatitis B	0.00012	0.0046
Disease-state	NC Mono	Kaposi sarcoma-associated herpesvirus infection	0.00027	0.0091
Disease-state	NC Mono	Human cytomegalovirus infection	0.00039	0.012
Disease-state	NC Mono	Transcriptional misregulation in cancer	0.00052	0.014
Disease-state	NC Mono	Leishmaniasis	0.001	0.026
Disease-state	NC Mono	Pathways in cancer	0.0013	0.027
Disease-state	NC Mono	Necroptosis	0.0013	0.027
Disease-state	NC Mono	Lipid and atherosclerosis	0.0014	0.027
Disease-state	NC Mono	RIG-I-like receptor signaling pathway	0.0018	0.032
Disease-state	NC Mono	Neutrophil extracellular trap formation	0.0018	0.032
Disease-state	NC Mono	Viral carcinogenesis	0.0028	0.047
Disease-state	NC Mono	Acute myeloid leukemia	0.003	0.048
Disease-state	NC Mono	Toxoplasmosis	0.0035	0.052
Disease-state	NC Mono	Chemokine signaling pathway	0.0039	0.056
Disease-state	NC Mono	PD-L1 expression and PD-1 checkpoint pathway in cancer	0.0043	0.058
Disease-state	NC Mono	Proteasome	0.0055	0.069
Disease-state	NC Mono	Circadian entrainment	0.0055	0.069
Disease-state	NC Mono	Toll-like receptor signaling pathway	0.0069	0.083
Disease-state	NC Mono	Osteoclast differentiation	0.008	0.09
Disease-state	NC Mono	AGE-RAGE signaling pathway in diabetic complications	0.0084	0.09
Disease-state	NC Mono	Pertussis	0.0084	0.09
Disease-state	NC Mono	Cytosolic DNA-sensing pathway	0.009	0.091
Disease-state	NC Mono	Circadian rhythm	0.0092	0.091
Disease-state	NC Mono	Phagosome	0.0094	0.091
Disease-state	NC Mono	Neuroactive ligand-receptor interaction	0.0097	0.091
Disease-state	NC Mono	Bladder cancer	0.01	0.093
Disease-state	NC Mono	JAK-STAT signaling pathway	0.011	0.095
Disease-state	NC Mono	Staphylococcus aureus infection	0.012	0.1
Disease-state	NC Mono	Antigen processing and presentation	0.012	0.1
Disease-state	NC Mono	Proteoglycans in cancer	0.013	0.1
Disease-state	NC Mono	MicroRNAs in cancer	0.014	0.11
Disease-state	NC Mono	Systemic lupus erythematosus	0.015	0.11
Disease-state	NC Mono	Chagas disease	0.015	0.11
Disease-state	NC Mono	Glioma	0.019	0.14
Disease-state	NC Mono	C-type lectin receptor signaling pathway	0.019	0.14
Disease-state	NC Mono	p53 signaling pathway	0.02	0.14
Disease-state	NC Mono	Ferroptosis	0.02	0.14
Disease-state	NC Mono	Human papillomavirus infection	0.022	0.15
Disease-state	NC Mono	HIF-1 signaling pathway	0.024	0.16
Disease-state	NC Mono	Steroid biosynthesis	0.025	0.16
Disease-state	NC Mono	Non-small cell lung cancer	0.027	0.17
Disease-state	NC Mono	Axon guidance	0.029	0.18
Disease-state	NC Mono	Chronic myeloid leukemia	0.03	0.18
Disease-state	NC Mono	Cellular senescence	0.03	0.18
Disease-state	NC Mono	Shigellosis	0.032	0.19
Disease-state	NC Mono	Renin secretion	0.035	0.2
Disease-state	NC Mono	Natural killer cell mediated cytotoxicity	0.037	0.2
Disease-state	NC Mono	Neurotrophin signaling pathway	0.038	0.21
Disease-state	NC Mono	Adipocytokine signaling pathway	0.04	0.22
Disease-state	NC Mono	B cell receptor signaling pathway	0.043	0.23
Disease-state	NC Mono	Complement and coagulation cascades	0.05	0.26
Disease-state	mDC	Proteasome	1.4e-19	4.4e-17
Disease-state	mDC	Parkinson disease	4.2e-08	6.6e-06
Disease-state	mDC	Epstein-Barr virus infection	1.2e-06	0.00013
Disease-state	mDC	Amyotrophic lateral sclerosis	8.7e-06	0.00069
Disease-state	mDC	Spinocerebellar ataxia	1.7e-05	0.001
Disease-state	mDC	Prion disease	3.2e-05	0.0015
Disease-state	mDC	Influenza A	3.4e-05	0.0015
Disease-state	mDC	Hepatitis C	9.5e-05	0.0038
Disease-state	mDC	Alzheimer disease	0.00028	0.0098
Disease-state	mDC	Protein processing in endoplasmic reticulum	0.00074	0.023
Disease-state	mDC	Huntington disease	0.002	0.053
Disease-state	mDC	Terpenoid backbone biosynthesis	0.002	0.053
Disease-state	mDC	Citrate cycle (TCA cycle)	0.003	0.072
Disease-state	mDC	Hepatitis B	0.0071	0.15
Disease-state	mDC	Ribosome biogenesis in eukaryotes	0.0072	0.15
Disease-state	mDC	Pathways of neurodegeneration - multiple diseases	0.0094	0.18
Disease-state	mDC	Mineral absorption	0.012	0.21
Disease-state	mDC	Steroid biosynthesis	0.013	0.23
Disease-state	mDC	Bladder cancer	0.018	0.3
Disease-state	mDC	RIG-I-like receptor signaling pathway	0.025	0.4
Disease-state	mDC	Transcriptional misregulation in cancer	0.029	0.41
Disease-state	mDC	Measles	0.03	0.41
Disease-state	mDC	Cytosolic DNA-sensing pathway	0.03	0.41
Disease-state	mDC	Circadian rhythm	0.031	0.41
Disease-state	mDC	Aminoacyl-tRNA biosynthesis	0.037	0.47
Disease-state	mDC	Proximal tubule bicarbonate reclamation	0.04	0.47
Disease-state	mDC	Human immunodeficiency virus 1 infection	0.041	0.47
Disease-state	mDC	Apoptosis	0.043	0.48
Disease-state	pDC	Proteasome	2.1e-08	6.4e-06
Disease-state	pDC	Influenza A	8.4e-08	1.3e-05
Disease-state	pDC	Epstein-Barr virus infection	2.4e-07	2.5e-05
Disease-state	pDC	Measles	8.1e-06	0.00063
Disease-state	pDC	Hepatitis C	2.4e-05	0.0015
Disease-state	pDC	PPAR signaling pathway	0.00048	0.025
Disease-state	pDC	Antigen processing and presentation	0.00059	0.026
Disease-state	pDC	Glycolysis / Gluconeogenesis	0.00092	0.036
Disease-state	pDC	Spinocerebellar ataxia	0.0024	0.084
Disease-state	pDC	NOD-like receptor signaling pathway	0.0035	0.11
Disease-state	pDC	Biosynthesis of amino acids	0.0053	0.15
Disease-state	pDC	Human immunodeficiency virus 1 infection	0.0059	0.15
Disease-state	pDC	Necroptosis	0.0075	0.18
Disease-state	pDC	Parkinson disease	0.011	0.24
Disease-state	pDC	Prostate cancer	0.013	0.27
Disease-state	pDC	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	0.021	0.41
Disease-state	pDC	Viral carcinogenesis	0.023	0.41
Disease-state	pDC	Kaposi sarcoma-associated herpesvirus infection	0.024	0.41
Disease-state	pDC	Steroid biosynthesis	0.026	0.43
Disease-state	pDC	Apoptosis	0.034	0.48
Disease-state	pDC	Lipid and atherosclerosis	0.039	0.48
Disease-state	pDC	Pyruvate metabolism	0.039	0.48
Disease-state	pDC	Natural killer cell mediated cytotoxicity	0.04	0.48
Disease-state	pDC	Prion disease	0.04	0.48
Disease-state	pDC	Human papillomavirus infection	0.041	0.48
Disease-state	pDC	Aminoacyl-tRNA biosynthesis	0.042	0.48
Disease-state	pDC	Adipocytokine signaling pathway	0.043	0.48
Disease-state	pDC	Viral myocarditis	0.043	0.48
Disease-state	pDC	Transcriptional misregulation in cancer	0.046	0.49
Disease-state	pDC	Apoptosis - multiple species	0.047	0.49
Disease-state	Neu	Coronavirus disease - COVID-19	3.3e-10	1.1e-07
Disease-state	Neu	Influenza A	8.2e-09	1.3e-06
Disease-state	Neu	NOD-like receptor signaling pathway	3.3e-07	3.5e-05
Disease-state	Neu	Ribosome	1.7e-05	0.0013
Disease-state	Neu	Necroptosis	6.1e-05	0.0037
Disease-state	Neu	Epstein-Barr virus infection	6.9e-05	0.0037
Disease-state	Neu	PD-L1 expression and PD-1 checkpoint pathway in cancer	8.2e-05	0.0038
Disease-state	Neu	Salmonella infection	0.00031	0.012
Disease-state	Neu	Measles	0.0004	0.014
Disease-state	Neu	Hepatitis C	0.00081	0.026
Disease-state	Neu	Sphingolipid signaling pathway	0.001	0.03
Disease-state	Neu	Chemical carcinogenesis - reactive oxygen species	0.0017	0.038
Disease-state	Neu	Apoptosis	0.0017	0.038
Disease-state	Neu	Autophagy - animal	0.0018	0.038
Disease-state	Neu	Longevity regulating pathway - multiple species	0.0019	0.038
Disease-state	Neu	Lipid and atherosclerosis	0.0019	0.038
Disease-state	Neu	Type II diabetes mellitus	0.002	0.038
Disease-state	Neu	Neutrophil extracellular trap formation	0.0022	0.039
Disease-state	Neu	Shigellosis	0.0032	0.051
Disease-state	Neu	AMPK signaling pathway	0.0032	0.051
Disease-state	Neu	Lysosome	0.005	0.076
Disease-state	Neu	Sphingolipid metabolism	0.0054	0.077
Disease-state	Neu	Fc epsilon RI signaling pathway	0.0055	0.077
Disease-state	Neu	Toll-like receptor signaling pathway	0.006	0.08
Disease-state	Neu	TNF signaling pathway	0.0074	0.094
Disease-state	Neu	Pancreatic cancer	0.0099	0.12
Disease-state	Neu	Longevity regulating pathway	0.013	0.15
Disease-state	Neu	Leishmaniasis	0.014	0.16
Disease-state	Neu	Ribosome biogenesis in eukaryotes	0.016	0.18
Disease-state	Neu	RIG-I-like receptor signaling pathway	0.018	0.18
Disease-state	Neu	EGFR tyrosine kinase inhibitor resistance	0.018	0.18
Disease-state	Neu	Human immunodeficiency virus 1 infection	0.02	0.19
Disease-state	Neu	Transcriptional misregulation in cancer	0.02	0.19
Disease-state	Neu	Tuberculosis	0.02	0.19
Disease-state	Neu	Progesterone-mediated oocyte maturation	0.024	0.22
Disease-state	Neu	Staphylococcus aureus infection	0.025	0.22
Disease-state	Neu	Acute myeloid leukemia	0.029	0.25
Disease-state	Neu	Apoptosis - multiple species	0.034	0.27
Disease-state	Neu	Cytosolic DNA-sensing pathway	0.034	0.27
Disease-state	Neu	Platinum drug resistance	0.034	0.27
Disease-state	Neu	Non-alcoholic fatty liver disease	0.035	0.27
Disease-state	Neu	Yersinia infection	0.036	0.27
Disease-state	Neu	Adipocytokine signaling pathway	0.036	0.27
Disease-state	Neu	Choline metabolism in cancer	0.036	0.27
Disease-state	Neu	Legionellosis	0.038	0.27
Disease-state	Neu	Proteasome	0.039	0.27
Disease-state	Neu	Fatty acid biosynthesis	0.04	0.27
Disease-state	Neu	JAK-STAT signaling pathway	0.04	0.27
Disease-state	Neu	Rheumatoid arthritis	0.042	0.27
Disease-state	Neu	Hepatitis B	0.043	0.27
Disease-state	Neu	Osteoclast differentiation	0.045	0.27
Disease-state	Neu	Th17 cell differentiation	0.045	0.27
Disease-state	Neu	Toxoplasmosis	0.045	0.27
Disease-state	Neu	Mitophagy - animal	0.047	0.28
Disease-state	Neu	Fanconi anemia pathway	0.047	0.28
Disease-state	Neu	Citrate cycle (TCA cycle)	0.05	0.28
Disease-state	Neu	Circadian rhythm	0.05	0.28
Disease-state	LDG	NOD-like receptor signaling pathway	9.8e-07	0.00031
Disease-state	LDG	Influenza A	6.1e-05	0.0097
Disease-state	LDG	Autophagy - animal	0.00059	0.052
Disease-state	LDG	Salmonella infection	0.00069	0.052
Disease-state	LDG	Pancreatic cancer	0.00081	0.052
Disease-state	LDG	PD-L1 expression and PD-1 checkpoint pathway in cancer	0.0015	0.07
Disease-state	LDG	Shigellosis	0.0016	0.07
Disease-state	LDG	Measles	0.0017	0.07
Disease-state	LDG	Epstein-Barr virus infection	0.0021	0.075
Disease-state	LDG	Neutrophil extracellular trap formation	0.0048	0.13
Disease-state	LDG	Longevity regulating pathway	0.005	0.13
Disease-state	LDG	Glycosphingolipid biosynthesis - lacto and neolacto series	0.005	0.13
Disease-state	LDG	RIG-I-like receptor signaling pathway	0.0054	0.13
Disease-state	LDG	Transcriptional misregulation in cancer	0.0076	0.17
Disease-state	LDG	Type II diabetes mellitus	0.0085	0.18
Disease-state	LDG	Necroptosis	0.0088	0.18
Disease-state	LDG	Apoptosis	0.011	0.2
Disease-state	LDG	IL-17 signaling pathway	0.011	0.2
Disease-state	LDG	Human cytomegalovirus infection	0.012	0.21
Disease-state	LDG	C-type lectin receptor signaling pathway	0.013	0.21
Disease-state	LDG	TNF signaling pathway	0.014	0.21
Disease-state	LDG	Cytosolic DNA-sensing pathway	0.016	0.23
Disease-state	LDG	Fc epsilon RI signaling pathway	0.019	0.26
Disease-state	LDG	Coronavirus disease - COVID-19	0.022	0.28
Disease-state	LDG	Longevity regulating pathway - multiple species	0.022	0.28
Disease-state	LDG	Human immunodeficiency virus 1 infection	0.023	0.28
Disease-state	LDG	AMPK signaling pathway	0.024	0.28
Disease-state	LDG	Glycolysis / Gluconeogenesis	0.037	0.41
Disease-state	LDG	Hepatitis C	0.04	0.41
Disease-state	LDG	Rap1 signaling pathway	0.04	0.41
Disease-state	LDG	Sphingolipid signaling pathway	0.04	0.41
Disease-state	LDG	RNA degradation	0.041	0.41
Disease-state	LDG	Ferroptosis	0.045	0.43
Disease-state	LDG	Choline metabolism in cancer	0.046	0.43
Disease-state	LDG	B cell receptor signaling pathway	0.048	0.44
Disease-state	LDG	Hepatitis B	0.05	0.44
Disease-activity	Naive CD4	Coronavirus disease - COVID-19	1.1e-36	3.5e-34
Disease-activity	Naive CD4	Ribosome	1.3e-30	2e-28
Disease-activity	Naive CD4	Influenza A	2.9e-10	2.9e-08
Disease-activity	Naive CD4	Necroptosis	1.3e-05	0.001
Disease-activity	Naive CD4	Hepatitis C	0.00025	0.015
Disease-activity	Naive CD4	NOD-like receptor signaling pathway	0.00073	0.037
Disease-activity	Naive CD4	RIG-I-like receptor signaling pathway	0.0025	0.11
Disease-activity	Naive CD4	Measles	0.0086	0.33
Disease-activity	Naive CD4	Cytosolic DNA-sensing pathway	0.014	0.46
Disease-activity	Naive CD4	Selenocompound metabolism	0.018	0.56
Disease-activity	Naive CD4	Folate biosynthesis	0.038	  1
Disease-activity	Naive CD4	Apoptosis	0.046	  1
Disease-activity	Mem CD4	Ribosome	6.1e-16	2e-13
Disease-activity	Mem CD4	Coronavirus disease - COVID-19	2.5e-14	4e-12
Disease-activity	Mem CD4	DNA replication	8e-06	0.00087
Disease-activity	Mem CD4	Cell cycle	5e-05	0.0041
Disease-activity	Mem CD4	Influenza A	0.0017	0.11
Disease-activity	Mem CD4	Hepatitis C	0.0028	0.15
Disease-activity	Mem CD4	One carbon pool by folate	0.0036	0.17
Disease-activity	Mem CD4	NOD-like receptor signaling pathway	0.0041	0.17
Disease-activity	Mem CD4	Lysosome	0.0048	0.17
Disease-activity	Mem CD4	Oocyte meiosis	0.0053	0.17
Disease-activity	Mem CD4	p53 signaling pathway	0.008	0.24
Disease-activity	Mem CD4	Nucleotide excision repair	0.0094	0.26
Disease-activity	Mem CD4	Dopaminergic synapse	0.012	0.3
Disease-activity	Mem CD4	Fanconi anemia pathway	0.015	0.36
Disease-activity	Mem CD4	Drug metabolism - other enzymes	0.021	0.45
Disease-activity	Mem CD4	MAPK signaling pathway	0.024	0.47
Disease-activity	Mem CD4	Human cytomegalovirus infection	0.025	0.47
Disease-activity	Mem CD4	RIG-I-like receptor signaling pathway	0.029	0.5
Disease-activity	Mem CD4	Cysteine and methionine metabolism	0.029	0.5
Disease-activity	Mem CD4	Kaposi sarcoma-associated herpesvirus infection	0.034	0.53
Disease-activity	Mem CD4	Chemical carcinogenesis - receptor activation	0.034	0.53
Disease-activity	Mem CD4	Cellular senescence	0.037	0.54
Disease-activity	Mem CD4	Glutamatergic synapse	0.038	0.54
Disease-activity	Mem CD4	Chemokine signaling pathway	0.04	0.54
Disease-activity	Mem CD4	Aminoacyl-tRNA biosynthesis	0.043	0.56
Disease-activity	Th1	Parkinson disease	1e-17	3.4e-15
Disease-activity	Th1	Oxidative phosphorylation	2.8e-13	4.6e-11
Disease-activity	Th1	Amyotrophic lateral sclerosis	2e-12	2.2e-10
Disease-activity	Th1	Huntington disease	3.6e-11	2.9e-09
Disease-activity	Th1	Prion disease	4.6e-11	3e-09
Disease-activity	Th1	Proteasome	1.3e-10	6.9e-09
Disease-activity	Th1	Pathways of neurodegeneration - multiple diseases	4.5e-10	2.1e-08
Disease-activity	Th1	Alzheimer disease	9.3e-10	3.8e-08
Disease-activity	Th1	Cell cycle	4.2e-08	1.5e-06
Disease-activity	Th1	Thermogenesis	5.8e-07	1.9e-05
Disease-activity	Th1	Chemical carcinogenesis - reactive oxygen species	1e-06	3e-05
Disease-activity	Th1	Diabetic cardiomyopathy	3e-06	8.1e-05
Disease-activity	Th1	DNA replication	3.8e-06	9.6e-05
Disease-activity	Th1	Non-alcoholic fatty liver disease	5.3e-06	0.00012
Disease-activity	Th1	Spliceosome	1.7e-05	0.00037
Disease-activity	Th1	Cardiac muscle contraction	3.2e-05	0.00065
Disease-activity	Th1	Carbon metabolism	0.00022	0.0042
Disease-activity	Th1	Oocyte meiosis	0.00049	0.0089
Disease-activity	Th1	Mismatch repair	0.00076	0.013
Disease-activity	Th1	Base excision repair	0.001	0.017
Disease-activity	Th1	Citrate cycle (TCA cycle)	0.0019	0.029
Disease-activity	Th1	Retrograde endocannabinoid signaling	0.0024	0.034
Disease-activity	Th1	Fanconi anemia pathway	0.0024	0.034
Disease-activity	Th1	Pentose phosphate pathway	0.0026	0.035
Disease-activity	Th1	Metabolic pathways	0.0028	0.036
Disease-activity	Th1	Ribosome	0.0032	0.04
Disease-activity	Th1	Biosynthesis of amino acids	0.0038	0.046
Disease-activity	Th1	Hepatitis C	0.0041	0.047
Disease-activity	Th1	Homologous recombination	0.0071	0.08
Disease-activity	Th1	Spinocerebellar ataxia	0.0089	0.096
Disease-activity	Th1	Nucleotide excision repair	0.011	0.11
Disease-activity	Th1	Aminoacyl-tRNA biosynthesis	0.013	0.13
Disease-activity	Th1	Pathogenic Escherichia coli infection	0.016	0.15
Disease-activity	Th1	Cysteine and methionine metabolism	0.017	0.16
Disease-activity	Th1	Biosynthesis of cofactors	0.018	0.17
Disease-activity	Th1	Pyrimidine metabolism	0.021	0.19
Disease-activity	Th1	Protein export	0.023	0.2
Disease-activity	Th1	p53 signaling pathway	0.024	0.2
Disease-activity	Th1	One carbon pool by folate	0.024	0.2
Disease-activity	Th1	mRNA surveillance pathway	0.025	0.2
Disease-activity	Th1	Fatty acid degradation	0.033	0.26
Disease-activity	Th2	Coronavirus disease - COVID-19	2.7e-32	8.6e-30
Disease-activity	Th2	Ribosome	2.9e-25	4.5e-23
Disease-activity	Th2	Influenza A	9.4e-09	9.8e-07
Disease-activity	Th2	RIG-I-like receptor signaling pathway	0.00048	0.038
Disease-activity	Th2	Hepatitis C	0.00097	0.061
Disease-activity	Th2	NOD-like receptor signaling pathway	0.007	0.33
Disease-activity	Th2	Cytosolic DNA-sensing pathway	0.0073	0.33
Disease-activity	Th2	Measles	0.01	0.39
Disease-activity	Th2	Salmonella infection	0.016	0.54
Disease-activity	Th2	Arginine and proline metabolism	0.017	0.54
Disease-activity	Th2	Necroptosis	0.023	0.61
Disease-activity	Th2	RNA degradation	0.023	0.61
Disease-activity	Th2	African trypanosomiasis	0.032	0.78
Disease-activity	Th2	Pathogenic Escherichia coli infection	0.037	0.84
Disease-activity	Th2	Kaposi sarcoma-associated herpesvirus infection	0.042	0.89
Disease-activity	Th2	Proximal tubule bicarbonate reclamation	0.049	0.97
Disease-activity	Th17	Coronavirus disease - COVID-19	3.8e-38	1.2e-35
Disease-activity	Th17	Ribosome	8e-35	1.2e-32
Disease-activity	Th17	Influenza A	8e-07	8.2e-05
Disease-activity	Th17	Hepatitis C	5.3e-05	0.0041
Disease-activity	Th17	Necroptosis	0.012	0.64
Disease-activity	Th17	Citrate cycle (TCA cycle)	0.012	0.64
Disease-activity	Th17	Apoptosis - multiple species	0.018	0.77
Disease-activity	Th17	Measles	0.02	0.77
Disease-activity	Th17	Carbon metabolism	0.024	0.81
Disease-activity	Th17	p53 signaling pathway	0.029	0.82
Disease-activity	Th17	Glyoxylate and dicarboxylate metabolism	0.029	0.82
Disease-activity	Th17	Pathways of neurodegeneration - multiple diseases	0.035	0.83
Disease-activity	Th17	JAK-STAT signaling pathway	0.036	0.83
Disease-activity	Th17	NOD-like receptor signaling pathway	0.04	0.83
Disease-activity	Th17	Proximal tubule bicarbonate reclamation	0.04	0.83
Disease-activity	Tfh	Coronavirus disease - COVID-19	8.3e-28	2.6e-25
Disease-activity	Tfh	Ribosome	3.6e-21	5.7e-19
Disease-activity	Tfh	Influenza A	4.2e-07	4.4e-05
Disease-activity	Tfh	Hepatitis C	0.00028	0.022
Disease-activity	Tfh	RIG-I-like receptor signaling pathway	0.00064	0.04
Disease-activity	Tfh	NOD-like receptor signaling pathway	0.0034	0.17
Disease-activity	Tfh	Proximal tubule bicarbonate reclamation	0.0037	0.17
Disease-activity	Tfh	Glycerolipid metabolism	0.0096	0.38
Disease-activity	Tfh	Other types of O-glycan biosynthesis	0.016	0.55
Disease-activity	Tfh	Cytosolic DNA-sensing pathway	0.02	0.64
Disease-activity	Tfh	Glyoxylate and dicarboxylate metabolism	0.024	0.68
Disease-activity	Tfh	One carbon pool by folate	0.026	0.69
Disease-activity	Tfh	Necroptosis	0.028	0.69
Disease-activity	Tfh	Mineral absorption	0.031	0.7
Disease-activity	Tfh	mTOR signaling pathway	0.034	0.71
Disease-activity	Tfh	Mitophagy - animal	0.037	0.74
Disease-activity	Tfh	Glutamatergic synapse	0.047	0.76
Disease-activity	Tfh	Mucin type O-glycan biosynthesis	0.049	0.76
Disease-activity	Fr. I nTreg	Coronavirus disease - COVID-19	7.4e-36	2.1e-33
Disease-activity	Fr. I nTreg	Ribosome	1.6e-27	2.3e-25
Disease-activity	Fr. I nTreg	Influenza A	2.3e-06	0.00022
Disease-activity	Fr. I nTreg	Hepatitis C	3.5e-05	0.002
Disease-activity	Fr. I nTreg	Measles	3.5e-05	0.002
Disease-activity	Fr. I nTreg	Necroptosis	0.00014	0.0066
Disease-activity	Fr. I nTreg	NOD-like receptor signaling pathway	0.00027	0.011
Disease-activity	Fr. I nTreg	Mitophagy - animal	0.0019	0.068
Disease-activity	Fr. I nTreg	Biosynthesis of cofactors	0.0043	0.14
Disease-activity	Fr. I nTreg	Epstein-Barr virus infection	0.0098	0.25
Disease-activity	Fr. I nTreg	RIG-I-like receptor signaling pathway	0.01	0.25
Disease-activity	Fr. I nTreg	Aminoacyl-tRNA biosynthesis	0.011	0.25
Disease-activity	Fr. I nTreg	Circadian rhythm	0.011	0.25
Disease-activity	Fr. I nTreg	JAK-STAT signaling pathway	0.015	0.31
Disease-activity	Fr. I nTreg	Cytosolic DNA-sensing pathway	0.019	0.36
Disease-activity	Fr. I nTreg	Folate biosynthesis	0.025	0.45
Disease-activity	Fr. II eTreg	Coronavirus disease - COVID-19	1.3e-11	3.9e-09
Disease-activity	Fr. II eTreg	Influenza A	3.9e-08	6e-06
Disease-activity	Fr. II eTreg	Ribosome	4.1e-06	0.00042
Disease-activity	Fr. II eTreg	Hepatitis C	0.00026	0.02
Disease-activity	Fr. II eTreg	Measles	0.0016	0.095
Disease-activity	Fr. II eTreg	NOD-like receptor signaling pathway	0.0021	0.11
Disease-activity	Fr. II eTreg	Cytokine-cytokine receptor interaction	0.0041	0.18
Disease-activity	Fr. II eTreg	RIG-I-like receptor signaling pathway	0.0071	0.27
Disease-activity	Fr. II eTreg	Lysosome	0.01	0.34
Disease-activity	Fr. II eTreg	Cytosolic DNA-sensing pathway	0.011	0.34
Disease-activity	Fr. II eTreg	Long-term potentiation	0.023	0.64
Disease-activity	Fr. II eTreg	Primary immunodeficiency	0.032	0.81
Disease-activity	Fr. II eTreg	Viral protein interaction with cytokine and cytokine receptor	0.044	  1
Disease-activity	Fr. II eTreg	Glycerophospholipid metabolism	0.049	  1
Disease-activity	Fr. II eTreg	Kaposi sarcoma-associated herpesvirus infection	0.049	  1
Disease-activity	Fr. III T	Coronavirus disease - COVID-19	9.8e-44	2.8e-41
Disease-activity	Fr. III T	Ribosome	1.2e-34	1.7e-32
Disease-activity	Fr. III T	Influenza A	2.4e-07	2.3e-05
Disease-activity	Fr. III T	Hepatitis C	0.00036	0.026
Disease-activity	Fr. III T	Mitophagy - animal	0.0021	0.12
Disease-activity	Fr. III T	NOD-like receptor signaling pathway	0.0044	0.21
Disease-activity	Fr. III T	Measles	0.0058	0.24
Disease-activity	Fr. III T	RIG-I-like receptor signaling pathway	0.011	0.39
Disease-activity	Fr. III T	Arginine and proline metabolism	0.031	0.88
Disease-activity	Fr. III T	Necroptosis	0.031	0.88
Disease-activity	Fr. III T	Kaposi sarcoma-associated herpesvirus infection	0.048	  1
Disease-activity	Naive CD8	Coronavirus disease - COVID-19	3.6e-24	1.1e-21
Disease-activity	Naive CD8	Ribosome	1.7e-18	2.6e-16
Disease-activity	Naive CD8	Influenza A	7.9e-08	8.2e-06
Disease-activity	Naive CD8	Hepatitis C	0.00056	0.044
Disease-activity	Naive CD8	p53 signaling pathway	0.0011	0.065
Disease-activity	Naive CD8	Necroptosis	0.0017	0.086
Disease-activity	Naive CD8	Measles	0.0029	0.12
Disease-activity	Naive CD8	RIG-I-like receptor signaling pathway	0.0033	0.12
Disease-activity	Naive CD8	Apoptosis - multiple species	0.0034	0.12
Disease-activity	Naive CD8	Mitophagy - animal	0.004	0.12
Disease-activity	Naive CD8	Shigellosis	0.0064	0.18
Disease-activity	Naive CD8	Natural killer cell mediated cytotoxicity	0.011	0.29
Disease-activity	Naive CD8	Pentose phosphate pathway	0.014	0.29
Disease-activity	Naive CD8	Glioma	0.014	0.29
Disease-activity	Naive CD8	Epstein-Barr virus infection	0.015	0.29
Disease-activity	Naive CD8	Melanoma	0.015	0.29
Disease-activity	Naive CD8	Apoptosis	0.017	0.29
Disease-activity	Naive CD8	Platinum drug resistance	0.018	0.29
Disease-activity	Naive CD8	NOD-like receptor signaling pathway	0.018	0.29
Disease-activity	Naive CD8	Glycerolipid metabolism	0.019	0.29
Disease-activity	Naive CD8	Non-small cell lung cancer	0.021	0.31
Disease-activity	Naive CD8	Mineral absorption	0.022	0.31
Disease-activity	Naive CD8	NF-kappa B signaling pathway	0.023	0.31
Disease-activity	Naive CD8	Thyroid cancer	0.026	0.34
Disease-activity	Naive CD8	Leishmaniasis	0.037	0.46
Disease-activity	Naive CD8	Biosynthesis of amino acids	0.049	0.59
Disease-activity	CM CD8	Ribosome	8.7e-09	2.7e-06
Disease-activity	CM CD8	Coronavirus disease - COVID-19	2.1e-06	0.00032
Disease-activity	CM CD8	Influenza A	6e-05	0.0063
Disease-activity	CM CD8	Cell cycle	9.4e-05	0.0074
Disease-activity	CM CD8	Proteasome	0.00044	0.026
Disease-activity	CM CD8	Parkinson disease	0.00054	0.026
Disease-activity	CM CD8	Huntington disease	0.00058	0.026
Disease-activity	CM CD8	Hepatitis C	0.001	0.039
Disease-activity	CM CD8	Amyotrophic lateral sclerosis	0.0013	0.047
Disease-activity	CM CD8	Pathways of neurodegeneration - multiple diseases	0.0025	0.08
Disease-activity	CM CD8	Pyrimidine metabolism	0.0036	0.1
Disease-activity	CM CD8	Mineral absorption	0.0079	0.21
Disease-activity	CM CD8	Drug metabolism - other enzymes	0.01	0.23
Disease-activity	CM CD8	One carbon pool by folate	0.01	0.23
Disease-activity	CM CD8	DNA replication	0.015	0.32
Disease-activity	CM CD8	Measles	0.016	0.32
Disease-activity	CM CD8	Necroptosis	0.02	0.36
Disease-activity	CM CD8	Citrate cycle (TCA cycle)	0.023	0.41
Disease-activity	CM CD8	Alzheimer disease	0.025	0.41
Disease-activity	CM CD8	Homologous recombination	0.027	0.41
Disease-activity	CM CD8	Salmonella infection	0.027	0.41
Disease-activity	CM CD8	Bacterial invasion of epithelial cells	0.032	0.41
Disease-activity	CM CD8	Proximal tubule bicarbonate reclamation	0.032	0.41
Disease-activity	CM CD8	Prion disease	0.034	0.41
Disease-activity	CM CD8	Oxidative phosphorylation	0.035	0.41
Disease-activity	CM CD8	Carbon metabolism	0.035	0.41
Disease-activity	CM CD8	Fanconi anemia pathway	0.035	0.41
Disease-activity	CM CD8	Metabolic pathways	0.037	0.41
Disease-activity	CM CD8	Epstein-Barr virus infection	0.04	0.42
Disease-activity	CM CD8	Apoptosis	0.041	0.42
Disease-activity	CM CD8	RNA degradation	0.042	0.42
Disease-activity	CM CD8	mRNA surveillance pathway	0.047	0.46
Disease-activity	EM CD8	Parkinson disease	8e-17	2.6e-14
Disease-activity	EM CD8	Proteasome	7.3e-16	1.2e-13
Disease-activity	EM CD8	Prion disease	5e-12	5.4e-10
Disease-activity	EM CD8	Ribosome	8.1e-12	6.6e-10
Disease-activity	EM CD8	Huntington disease	5.5e-11	3.5e-09
Disease-activity	EM CD8	Amyotrophic lateral sclerosis	5.8e-10	3.2e-08
Disease-activity	EM CD8	Pathways of neurodegeneration - multiple diseases	1.6e-09	7.4e-08
Disease-activity	EM CD8	Alzheimer disease	3.5e-07	1.4e-05
Disease-activity	EM CD8	Cell cycle	6.6e-07	2.4e-05
Disease-activity	EM CD8	Oxidative phosphorylation	1.3e-06	4.2e-05
Disease-activity	EM CD8	DNA replication	2.7e-06	7.9e-05
Disease-activity	EM CD8	Chemical carcinogenesis - reactive oxygen species	0.00014	0.0039
Disease-activity	EM CD8	Carbon metabolism	0.00017	0.0042
Disease-activity	EM CD8	Coronavirus disease - COVID-19	0.00034	0.0076
Disease-activity	EM CD8	Homologous recombination	0.00035	0.0076
Disease-activity	EM CD8	Biosynthesis of amino acids	0.00052	0.01
Disease-activity	EM CD8	Thermogenesis	0.00082	0.016
Disease-activity	EM CD8	Cardiac muscle contraction	0.001	0.019
Disease-activity	EM CD8	Citrate cycle (TCA cycle)	0.0011	0.019
Disease-activity	EM CD8	Glyoxylate and dicarboxylate metabolism	0.0012	0.02
Disease-activity	EM CD8	Mismatch repair	0.0014	0.021
Disease-activity	EM CD8	Non-alcoholic fatty liver disease	0.0015	0.021
Disease-activity	EM CD8	Diabetic cardiomyopathy	0.0015	0.021
Disease-activity	EM CD8	Oocyte meiosis	0.0025	0.034
Disease-activity	EM CD8	Ubiquinone and other terpenoid-quinone biosynthesis	0.0029	0.037
Disease-activity	EM CD8	Fanconi anemia pathway	0.0031	0.038
Disease-activity	EM CD8	Hepatitis C	0.0039	0.047
Disease-activity	EM CD8	Cellular senescence	0.0063	0.073
Disease-activity	EM CD8	Spliceosome	0.0067	0.075
Disease-activity	EM CD8	p53 signaling pathway	0.0087	0.093
Disease-activity	EM CD8	Pyrimidine metabolism	0.0089	0.093
Disease-activity	EM CD8	Protein export	0.0093	0.094
Disease-activity	EM CD8	Biosynthesis of cofactors	0.013	0.13
Disease-activity	EM CD8	Spinocerebellar ataxia	0.015	0.15
Disease-activity	EM CD8	Necroptosis	0.016	0.15
Disease-activity	EM CD8	Influenza A	0.019	0.18
Disease-activity	EM CD8	Pentose phosphate pathway	0.023	0.2
Disease-activity	EM CD8	Metabolic pathways	0.025	0.21
Disease-activity	EM CD8	One carbon pool by folate	0.026	0.21
Disease-activity	EM CD8	2-Oxocarboxylic acid metabolism	0.026	0.21
Disease-activity	EM CD8	Glycine, serine and threonine metabolism	0.029	0.23
Disease-activity	EM CD8	Cysteine and methionine metabolism	0.04	0.3
Disease-activity	EM CD8	Arginine and proline metabolism	0.041	0.3
Disease-activity	EM CD8	Base excision repair	0.041	0.3
Disease-activity	TEMRA CD8	Coronavirus disease - COVID-19	4.5e-19	1.4e-16
Disease-activity	TEMRA CD8	Ribosome	3.9e-18	6.2e-16
Disease-activity	TEMRA CD8	Cell cycle	2.9e-07	3.1e-05
Disease-activity	TEMRA CD8	Influenza A	2.4e-05	0.0019
Disease-activity	TEMRA CD8	DNA replication	7.9e-05	0.005
Disease-activity	TEMRA CD8	Hepatitis C	0.00027	0.015
Disease-activity	TEMRA CD8	Fanconi anemia pathway	0.0012	0.056
Disease-activity	TEMRA CD8	Citrate cycle (TCA cycle)	0.0017	0.069
Disease-activity	TEMRA CD8	Proteasome	0.0025	0.089
Disease-activity	TEMRA CD8	Oocyte meiosis	0.0035	0.11
Disease-activity	TEMRA CD8	Apoptosis	0.0077	0.22
Disease-activity	TEMRA CD8	Homologous recombination	0.0083	0.22
Disease-activity	TEMRA CD8	Glioma	0.0099	0.22
Disease-activity	TEMRA CD8	Mitophagy - animal	0.011	0.22
Disease-activity	TEMRA CD8	Parkinson disease	0.011	0.22
Disease-activity	TEMRA CD8	Biosynthesis of amino acids	0.011	0.22
Disease-activity	TEMRA CD8	MicroRNAs in cancer	0.012	0.22
Disease-activity	TEMRA CD8	Epstein-Barr virus infection	0.013	0.22
Disease-activity	TEMRA CD8	Measles	0.013	0.22
Disease-activity	TEMRA CD8	Carbon metabolism	0.016	0.26
Disease-activity	TEMRA CD8	Melanoma	0.017	0.26
Disease-activity	TEMRA CD8	Gap junction	0.024	0.34
Disease-activity	TEMRA CD8	Kaposi sarcoma-associated herpesvirus infection	0.026	0.35
Disease-activity	TEMRA CD8	Glyoxylate and dicarboxylate metabolism	0.026	0.35
Disease-activity	TEMRA CD8	RIG-I-like receptor signaling pathway	0.031	0.4
Disease-activity	TEMRA CD8	Thyroid cancer	0.034	0.41
Disease-activity	TEMRA CD8	Non-small cell lung cancer	0.034	0.41
Disease-activity	TEMRA CD8	Pyrimidine metabolism	0.036	0.41
Disease-activity	TEMRA CD8	p53 signaling pathway	0.041	0.44
Disease-activity	TEMRA CD8	Ubiquinone and other terpenoid-quinone biosynthesis	0.042	0.44
Disease-activity	TEMRA CD8	Bladder cancer	0.043	0.44
Disease-activity	TEMRA CD8	Pathways of neurodegeneration - multiple diseases	0.045	0.45
Disease-activity	TEMRA CD8	Salmonella infection	0.048	0.46
Disease-activity	NK	Cell cycle	1.1e-09	3.6e-07
Disease-activity	NK	Coronavirus disease - COVID-19	1.1e-06	0.00017
Disease-activity	NK	Hepatitis C	3.3e-06	0.00035
Disease-activity	NK	DNA replication	5.3e-06	0.00042
Disease-activity	NK	p53 signaling pathway	2.4e-05	0.0015
Disease-activity	NK	Ribosome	0.00011	0.006
Disease-activity	NK	Influenza A	0.00025	0.012
Disease-activity	NK	Epstein-Barr virus infection	0.00067	0.024
Disease-activity	NK	Fanconi anemia pathway	0.00069	0.024
Disease-activity	NK	Mitophagy - animal	0.00091	0.029
Disease-activity	NK	Homologous recombination	0.0013	0.039
Disease-activity	NK	Measles	0.0017	0.044
Disease-activity	NK	Oocyte meiosis	0.0018	0.044
Disease-activity	NK	MicroRNAs in cancer	0.0024	0.054
Disease-activity	NK	Hepatitis B	0.0028	0.06
Disease-activity	NK	Melanoma	0.0048	0.097
Disease-activity	NK	Bladder cancer	0.0075	0.14
Disease-activity	NK	Glioma	0.0088	0.16
Disease-activity	NK	Cellular senescence	0.0096	0.16
Disease-activity	NK	Viral carcinogenesis	0.0099	0.16
Disease-activity	NK	One carbon pool by folate	0.013	0.2
Disease-activity	NK	Kaposi sarcoma-associated herpesvirus infection	0.014	0.21
Disease-activity	NK	Citrate cycle (TCA cycle)	0.015	0.21
Disease-activity	NK	Non-small cell lung cancer	0.017	0.22
Disease-activity	NK	Apoptosis	0.018	0.23
Disease-activity	NK	Gap junction	0.019	0.24
Disease-activity	NK	Necroptosis	0.022	0.27
Disease-activity	NK	Platinum drug resistance	0.027	0.29
Disease-activity	NK	Pathogenic Escherichia coli infection	0.027	0.29
Disease-activity	NK	Human papillomavirus infection	0.031	0.33
Disease-activity	NK	Pancreatic cancer	0.032	0.33
Disease-activity	NK	Base excision repair	0.035	0.33
Disease-activity	NK	Thyroid cancer	0.035	0.33
Disease-activity	NK	Drug metabolism - other enzymes	0.035	0.33
Disease-activity	NK	Biosynthesis of amino acids	0.038	0.35
Disease-activity	NK	Proteasome	0.043	0.37
Disease-activity	NK	RIG-I-like receptor signaling pathway	0.045	0.37
Disease-activity	NK	Breast cancer	0.045	0.37
Disease-activity	NK	Glutathione metabolism	0.047	0.37
Disease-activity	NK	mRNA surveillance pathway	0.047	0.37
Disease-activity	NK	Human immunodeficiency virus 1 infection	0.048	0.37
Disease-activity	NK	Pyrimidine metabolism	0.048	0.37
Disease-activity	NK	Prolactin signaling pathway	0.049	0.37
Disease-activity	Naive B	Coronavirus disease - COVID-19	7.8e-30	2.5e-27
Disease-activity	Naive B	Ribosome	9.3e-26	1.5e-23
Disease-activity	Naive B	Influenza A	3e-07	3.2e-05
Disease-activity	Naive B	Hepatitis C	0.00054	0.043
Disease-activity	Naive B	Necroptosis	0.0016	0.1
Disease-activity	Naive B	RIG-I-like receptor signaling pathway	0.0052	0.28
Disease-activity	Naive B	Measles	0.011	0.51
Disease-activity	Naive B	Kaposi sarcoma-associated herpesvirus infection	0.013	0.51
Disease-activity	Naive B	Epstein-Barr virus infection	0.018	0.62
Disease-activity	Naive B	Ascorbate and aldarate metabolism	0.023	0.72
Disease-activity	Naive B	2-Oxocarboxylic acid metabolism	0.025	0.72
Disease-activity	Naive B	Folate biosynthesis	0.033	0.74
Disease-activity	Naive B	Citrate cycle (TCA cycle)	0.033	0.74
Disease-activity	Naive B	Arginine and proline metabolism	0.035	0.74
Disease-activity	Naive B	Salmonella infection	0.035	0.74
Disease-activity	Naive B	Bladder cancer	0.041	0.79
Disease-activity	Naive B	Retinol metabolism	0.042	0.79
Disease-activity	Naive B	Cytosolic DNA-sensing pathway	0.045	0.79
Disease-activity	Naive B	Pyruvate metabolism	0.048	0.8
Disease-activity	USM B	Coronavirus disease - COVID-19	1.1e-29	3.5e-27
Disease-activity	USM B	Ribosome	2e-22	3.1e-20
Disease-activity	USM B	Influenza A	8.1e-07	8.3e-05
Disease-activity	USM B	NOD-like receptor signaling pathway	0.00028	0.021
Disease-activity	USM B	Hepatitis C	0.00045	0.028
Disease-activity	USM B	2-Oxocarboxylic acid metabolism	0.0015	0.072
Disease-activity	USM B	Biosynthesis of amino acids	0.0017	0.072
Disease-activity	USM B	RIG-I-like receptor signaling pathway	0.0019	0.072
Disease-activity	USM B	JAK-STAT signaling pathway	0.0051	0.17
Disease-activity	USM B	Measles	0.0058	0.17
Disease-activity	USM B	Glyoxylate and dicarboxylate metabolism	0.0061	0.17
Disease-activity	USM B	HIF-1 signaling pathway	0.011	0.29
Disease-activity	USM B	Renin-angiotensin system	0.014	0.33
Disease-activity	USM B	Kaposi sarcoma-associated herpesvirus infection	0.022	0.49
Disease-activity	USM B	Necroptosis	0.028	0.58
Disease-activity	USM B	Carbon metabolism	0.031	0.61
Disease-activity	USM B	Epstein-Barr virus infection	0.039	0.7
Disease-activity	USM B	Sphingolipid metabolism	0.043	0.74
Disease-activity	SM B	Coronavirus disease - COVID-19	1.5e-30	4.8e-28
Disease-activity	SM B	Ribosome	8.9e-23	1.4e-20
Disease-activity	SM B	Influenza A	1.7e-07	1.8e-05
Disease-activity	SM B	NOD-like receptor signaling pathway	0.00095	0.075
Disease-activity	SM B	Biosynthesis of amino acids	0.0016	0.099
Disease-activity	SM B	Glycolysis / Gluconeogenesis	0.002	0.1
Disease-activity	SM B	HIF-1 signaling pathway	0.0037	0.16
Disease-activity	SM B	African trypanosomiasis	0.0042	0.16
Disease-activity	SM B	Glyoxylate and dicarboxylate metabolism	0.0055	0.19
Disease-activity	SM B	Carbon metabolism	0.0067	0.21
Disease-activity	SM B	Hepatitis C	0.0086	0.22
Disease-activity	SM B	Measles	0.0086	0.22
Disease-activity	SM B	Pyruvate metabolism	0.015	0.37
Disease-activity	SM B	Fat digestion and absorption	0.017	0.37
Disease-activity	SM B	Fructose and mannose metabolism	0.018	0.37
Disease-activity	SM B	RIG-I-like receptor signaling pathway	0.029	0.56
Disease-activity	SM B	Renin-angiotensin system	0.03	0.56
Disease-activity	SM B	JAK-STAT signaling pathway	0.043	0.73
Disease-activity	SM B	Lysine degradation	0.045	0.73
Disease-activity	SM B	Kaposi sarcoma-associated herpesvirus infection	0.047	0.73
Disease-activity	SM B	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	0.049	0.73
Disease-activity	DN B	Coronavirus disease - COVID-19	1.5e-37	4.2e-35
Disease-activity	DN B	Ribosome	1.9e-31	2.7e-29
Disease-activity	DN B	Influenza A	2.8e-06	0.00026
Disease-activity	DN B	Hepatitis C	0.00094	0.053
Disease-activity	DN B	Measles	0.00094	0.053
Disease-activity	DN B	2-Oxocarboxylic acid metabolism	0.0034	0.16
Disease-activity	DN B	JAK-STAT signaling pathway	0.007	0.28
Disease-activity	DN B	NOD-like receptor signaling pathway	0.0091	0.32
Disease-activity	DN B	RIG-I-like receptor signaling pathway	0.011	0.34
Disease-activity	DN B	Fat digestion and absorption	0.016	0.44
Disease-activity	DN B	Biosynthesis of amino acids	0.022	0.55
Disease-activity	DN B	Folate biosynthesis	0.026	0.6
Disease-activity	DN B	Arginine and proline metabolism	0.031	0.64
Disease-activity	DN B	Linoleic acid metabolism	0.032	0.64
Disease-activity	DN B	Bladder cancer	0.035	0.65
Disease-activity	DN B	Epstein-Barr virus infection	0.038	0.65
Disease-activity	DN B	Renin-angiotensin system	0.042	0.65
Disease-activity	DN B	Citrate cycle (TCA cycle)	0.044	0.65
Disease-activity	DN B	Arachidonic acid metabolism	0.045	0.65
Disease-activity	DN B	Kaposi sarcoma-associated herpesvirus infection	0.047	0.65
Disease-activity	DN B	HIF-1 signaling pathway	0.048	0.65
Disease-activity	Plasmablast	DNA replication	1.1e-07	3.5e-05
Disease-activity	Plasmablast	Amyotrophic lateral sclerosis	4.6e-07	7.4e-05
Disease-activity	Plasmablast	Parkinson disease	2.2e-06	0.00021
Disease-activity	Plasmablast	Cell cycle	2.6e-06	0.00021
Disease-activity	Plasmablast	Fanconi anemia pathway	1.7e-05	0.0011
Disease-activity	Plasmablast	Homologous recombination	9e-05	0.0049
Disease-activity	Plasmablast	Proteasome	0.00013	0.0061
Disease-activity	Plasmablast	Ribosome biogenesis in eukaryotes	0.00036	0.015
Disease-activity	Plasmablast	Mismatch repair	0.00047	0.017
Disease-activity	Plasmablast	Huntington disease	0.0006	0.019
Disease-activity	Plasmablast	Prion disease	0.00078	0.023
Disease-activity	Plasmablast	Pathways of neurodegeneration - multiple diseases	0.0012	0.033
Disease-activity	Plasmablast	Epstein-Barr virus infection	0.0014	0.036
Disease-activity	Plasmablast	Nucleocytoplasmic transport	0.0027	0.061
Disease-activity	Plasmablast	Thermogenesis	0.0028	0.061
Disease-activity	Plasmablast	p53 signaling pathway	0.0034	0.068
Disease-activity	Plasmablast	Measles	0.0037	0.068
Disease-activity	Plasmablast	Base excision repair	0.0038	0.068
Disease-activity	Plasmablast	Oxidative phosphorylation	0.007	0.11
Disease-activity	Plasmablast	Alzheimer disease	0.007	0.11
Disease-activity	Plasmablast	RNA degradation	0.009	0.14
Disease-activity	Plasmablast	Oocyte meiosis	0.011	0.16
Disease-activity	Plasmablast	Necroptosis	0.015	0.22
Disease-activity	Plasmablast	Mucin type O-glycan biosynthesis	0.018	0.24
Disease-activity	Plasmablast	Influenza A	0.02	0.25
Disease-activity	Plasmablast	Cellular senescence	0.02	0.25
Disease-activity	Plasmablast	Pyrimidine metabolism	0.023	0.28
Disease-activity	Plasmablast	Progesterone-mediated oocyte maturation	0.029	0.34
Disease-activity	Plasmablast	Hepatitis C	0.03	0.34
Disease-activity	Plasmablast	Apoptosis	0.032	0.34
Disease-activity	Plasmablast	Nucleotide excision repair	0.033	0.34
Disease-activity	Plasmablast	Biosynthesis of cofactors	0.036	0.37
Disease-activity	Plasmablast	Retrograde endocannabinoid signaling	0.038	0.37
Disease-activity	Plasmablast	Coronavirus disease - COVID-19	0.041	0.4
Disease-activity	Plasmablast	RIG-I-like receptor signaling pathway	0.044	0.4
Disease-activity	CL Mono	Coronavirus disease - COVID-19	9.9e-15	3.2e-12
Disease-activity	CL Mono	Ribosome	4.1e-08	6.7e-06
Disease-activity	CL Mono	Influenza A	2e-07	2.2e-05
Disease-activity	CL Mono	Tuberculosis	1.2e-06	9.8e-05
Disease-activity	CL Mono	Leishmaniasis	6.5e-06	0.00042
Disease-activity	CL Mono	Staphylococcus aureus infection	3.6e-05	0.002
Disease-activity	CL Mono	NOD-like receptor signaling pathway	7.9e-05	0.0036
Disease-activity	CL Mono	Asthma	0.00048	0.017
Disease-activity	CL Mono	Lipid and atherosclerosis	0.00054	0.017
Disease-activity	CL Mono	Necroptosis	0.00056	0.017
Disease-activity	CL Mono	Pertussis	0.00058	0.017
Disease-activity	CL Mono	Phagosome	0.00071	0.019
Disease-activity	CL Mono	Antigen processing and presentation	0.0015	0.038
Disease-activity	CL Mono	Toxoplasmosis	0.0016	0.038
Disease-activity	CL Mono	Type I diabetes mellitus	0.0021	0.044
Disease-activity	CL Mono	Rheumatoid arthritis	0.0022	0.044
Disease-activity	CL Mono	Hepatitis C	0.0025	0.048
Disease-activity	CL Mono	Systemic lupus erythematosus	0.003	0.055
Disease-activity	CL Mono	Epstein-Barr virus infection	0.0049	0.082
Disease-activity	CL Mono	Human immunodeficiency virus 1 infection	0.0051	0.082
Disease-activity	CL Mono	Legionellosis	0.0067	0.099
Disease-activity	CL Mono	Osteoclast differentiation	0.0067	0.099
Disease-activity	CL Mono	IL-17 signaling pathway	0.0092	0.13
Disease-activity	CL Mono	Pentose and glucuronate interconversions	0.01	0.14
Disease-activity	CL Mono	Inflammatory bowel disease	0.011	0.15
Disease-activity	CL Mono	Salmonella infection	0.012	0.15
Disease-activity	CL Mono	Human cytomegalovirus infection	0.014	0.16
Disease-activity	CL Mono	Neutrophil extracellular trap formation	0.014	0.16
Disease-activity	CL Mono	Kaposi sarcoma-associated herpesvirus infection	0.014	0.16
Disease-activity	CL Mono	Acute myeloid leukemia	0.014	0.16
Disease-activity	CL Mono	Allograft rejection	0.019	0.2
Disease-activity	CL Mono	Graft-versus-host disease	0.019	0.2
Disease-activity	CL Mono	Estrogen signaling pathway	0.02	0.2
Disease-activity	CL Mono	RIG-I-like receptor signaling pathway	0.023	0.21
Disease-activity	CL Mono	Shigellosis	0.023	0.21
Disease-activity	CL Mono	Hepatitis B	0.024	0.22
Disease-activity	CL Mono	2-Oxocarboxylic acid metabolism	0.03	0.25
Disease-activity	CL Mono	JAK-STAT signaling pathway	0.03	0.25
Disease-activity	CL Mono	Hematopoietic cell lineage	0.031	0.26
Disease-activity	CL Mono	DNA replication	0.035	0.28
Disease-activity	CL Mono	Cytosolic DNA-sensing pathway	0.036	0.28
Disease-activity	CL Mono	Pathogenic Escherichia coli infection	0.038	0.29
Disease-activity	CL Mono	Amoebiasis	0.039	0.29
Disease-activity	CL Mono	Toll-like receptor signaling pathway	0.042	0.29
Disease-activity	CL Mono	Citrate cycle (TCA cycle)	0.042	0.29
Disease-activity	CL Mono	Viral myocarditis	0.044	0.29
Disease-activity	CL Mono	Autoimmune thyroid disease	0.044	0.29
Disease-activity	CL Mono	Salivary secretion	0.045	0.29
Disease-activity	CL Mono	C-type lectin receptor signaling pathway	0.045	0.29
Disease-activity	CL Mono	Folate biosynthesis	0.045	0.29
Disease-activity	CD16p Mono	Coronavirus disease - COVID-19	1.4e-19	4.6e-17
Disease-activity	CD16p Mono	Ribosome	2.7e-12	4.5e-10
Disease-activity	CD16p Mono	Neutrophil extracellular trap formation	0.00037	0.04
Disease-activity	CD16p Mono	Systemic lupus erythematosus	0.00068	0.051
Disease-activity	CD16p Mono	Necroptosis	0.00079	0.051
Disease-activity	CD16p Mono	Alcoholism	0.004	0.2
Disease-activity	CD16p Mono	Staphylococcus aureus infection	0.0045	0.2
Disease-activity	CD16p Mono	Influenza A	0.0049	0.2
Disease-activity	CD16p Mono	Lysosome	0.01	0.36
Disease-activity	CD16p Mono	Thyroid cancer	0.012	0.38
Disease-activity	CD16p Mono	Hepatitis C	0.026	0.67
Disease-activity	CD16p Mono	Viral carcinogenesis	0.027	0.67
Disease-activity	CD16p Mono	Cytosolic DNA-sensing pathway	0.027	0.67
Disease-activity	CD16p Mono	Glycosaminoglycan degradation	0.029	0.67
Disease-activity	CD16p Mono	NOD-like receptor signaling pathway	0.031	0.67
Disease-activity	CD16p Mono	Pancreatic secretion	0.034	0.69
Disease-activity	CD16p Mono	Carbon metabolism	0.04	0.76
Disease-activity	CD16p Mono	Human cytomegalovirus infection	0.045	0.81
Disease-activity	CD16p Mono	Transcriptional misregulation in cancer	0.048	0.83
Disease-activity	Int Mono	Coronavirus disease - COVID-19	5.8e-28	1.9e-25
Disease-activity	Int Mono	Ribosome	7e-21	1.1e-18
Disease-activity	Int Mono	Systemic lupus erythematosus	8.9e-08	9.5e-06
Disease-activity	Int Mono	Influenza A	2.3e-05	0.0018
Disease-activity	Int Mono	Neutrophil extracellular trap formation	4.3e-05	0.0028
Disease-activity	Int Mono	Staphylococcus aureus infection	0.00071	0.038
Disease-activity	Int Mono	Necroptosis	0.0014	0.066
Disease-activity	Int Mono	Alcoholism	0.004	0.16
Disease-activity	Int Mono	Cytosolic DNA-sensing pathway	0.0089	0.3
Disease-activity	Int Mono	Aminoacyl-tRNA biosynthesis	0.0094	0.3
Disease-activity	Int Mono	Nucleotide excision repair	0.016	0.47
Disease-activity	Int Mono	RNA degradation	0.019	0.51
Disease-activity	Int Mono	Porphyrin and chlorophyll metabolism	0.023	0.58
Disease-activity	Int Mono	Glycosphingolipid biosynthesis - ganglio series	0.039	0.78
Disease-activity	Int Mono	Non-homologous end-joining	0.039	0.78
Disease-activity	Int Mono	Hepatitis C	0.041	0.78
Disease-activity	Int Mono	Other glycan degradation	0.041	0.78
Disease-activity	Int Mono	HIF-1 signaling pathway	0.05	0.89
Disease-activity	NC Mono	Coronavirus disease - COVID-19	4.9e-21	1.6e-18
Disease-activity	NC Mono	Ribosome	2.6e-15	4.3e-13
Disease-activity	NC Mono	Systemic lupus erythematosus	4e-06	0.00043
Disease-activity	NC Mono	Neutrophil extracellular trap formation	0.00024	0.016
Disease-activity	NC Mono	Necroptosis	0.00025	0.016
Disease-activity	NC Mono	Influenza A	0.0003	0.016
Disease-activity	NC Mono	Alcoholism	0.00057	0.027
Disease-activity	NC Mono	RNA degradation	0.0022	0.09
Disease-activity	NC Mono	NOD-like receptor signaling pathway	0.0041	0.14
Disease-activity	NC Mono	Pertussis	0.0043	0.14
Disease-activity	NC Mono	Non-homologous end-joining	0.005	0.15
Disease-activity	NC Mono	Folate biosynthesis	0.009	0.24
Disease-activity	NC Mono	Aminoacyl-tRNA biosynthesis	0.0099	0.25
Disease-activity	NC Mono	Cytosolic DNA-sensing pathway	0.011	0.25
Disease-activity	NC Mono	Nucleotide excision repair	0.013	0.28
Disease-activity	NC Mono	Circadian rhythm	0.015	0.3
Disease-activity	NC Mono	Staphylococcus aureus infection	0.017	0.3
Disease-activity	NC Mono	Viral carcinogenesis	0.017	0.3
Disease-activity	NC Mono	Chronic myeloid leukemia	0.018	0.3
Disease-activity	NC Mono	Glyoxylate and dicarboxylate metabolism	0.023	0.37
Disease-activity	NC Mono	RIG-I-like receptor signaling pathway	0.026	0.39
Disease-activity	NC Mono	Hepatitis C	0.027	0.4
Disease-activity	NC Mono	Carbon metabolism	0.037	0.51
Disease-activity	NC Mono	Lysosome	0.038	0.51
Disease-activity	NC Mono	Hepatitis B	0.039	0.51
Disease-activity	NC Mono	HIF-1 signaling pathway	0.043	0.54
Disease-activity	mDC	Coronavirus disease - COVID-19	2.4e-25	7.5e-23
Disease-activity	mDC	Ribosome	1.2e-13	1.9e-11
Disease-activity	mDC	Influenza A	1.3e-06	0.00014
Disease-activity	mDC	RIG-I-like receptor signaling pathway	1.3e-05	0.00096
Disease-activity	mDC	Pertussis	1.5e-05	0.00096
Disease-activity	mDC	Kaposi sarcoma-associated herpesvirus infection	2.3e-05	0.0012
Disease-activity	mDC	Measles	4.6e-05	0.0021
Disease-activity	mDC	Hepatitis C	0.00029	0.012
Disease-activity	mDC	Legionellosis	0.00051	0.018
Disease-activity	mDC	Human immunodeficiency virus 1 infection	0.00079	0.025
Disease-activity	mDC	NOD-like receptor signaling pathway	0.0018	0.05
Disease-activity	mDC	Systemic lupus erythematosus	0.0028	0.073
Disease-activity	mDC	Shigellosis	0.0034	0.083
Disease-activity	mDC	Pathogenic Escherichia coli infection	0.0039	0.084
Disease-activity	mDC	Epstein-Barr virus infection	0.004	0.084
Disease-activity	mDC	Human cytomegalovirus infection	0.0044	0.086
Disease-activity	mDC	Hepatitis B	0.0072	0.13
Disease-activity	mDC	Toll-like receptor signaling pathway	0.0074	0.13
Disease-activity	mDC	Lipid and atherosclerosis	0.0097	0.16
Disease-activity	mDC	Natural killer cell mediated cytotoxicity	0.01	0.16
Disease-activity	mDC	Salmonella infection	0.011	0.16
Disease-activity	mDC	Staphylococcus aureus infection	0.011	0.16
Disease-activity	mDC	Epithelial cell signaling in Helicobacter pylori infection	0.012	0.16
Disease-activity	mDC	Yersinia infection	0.013	0.17
Disease-activity	mDC	JAK-STAT signaling pathway	0.017	0.22
Disease-activity	mDC	Transcriptional misregulation in cancer	0.019	0.23
Disease-activity	mDC	Arrhythmogenic right ventricular cardiomyopathy	0.021	0.23
Disease-activity	mDC	Alcoholic liver disease	0.021	0.23
Disease-activity	mDC	NF-kappa B signaling pathway	0.021	0.23
Disease-activity	mDC	Purine metabolism	0.026	0.27
Disease-activity	mDC	Bacterial invasion of epithelial cells	0.027	0.27
Disease-activity	mDC	Chemokine signaling pathway	0.028	0.27
Disease-activity	mDC	Viral carcinogenesis	0.029	0.27
Disease-activity	mDC	Necroptosis	0.029	0.27
Disease-activity	mDC	Nicotinate and nicotinamide metabolism	0.03	0.27
Disease-activity	mDC	Phototransduction	0.034	0.3
Disease-activity	mDC	Viral myocarditis	0.037	0.31
Disease-activity	mDC	Cytosolic DNA-sensing pathway	0.049	0.4
Disease-activity	mDC	Adrenergic signaling in cardiomyocytes	0.049	0.4
Disease-activity	pDC	Proteasome	1.5e-10	4.8e-08
Disease-activity	pDC	Epstein-Barr virus infection	3.8e-06	0.00036
Disease-activity	pDC	Prion disease	4.6e-06	0.00036
Disease-activity	pDC	Huntington disease	5.5e-06	0.00036
Disease-activity	pDC	Spinocerebellar ataxia	5.6e-06	0.00036
Disease-activity	pDC	Influenza A	7.7e-06	0.00041
Disease-activity	pDC	Parkinson disease	1.2e-05	0.00054
Disease-activity	pDC	Amyotrophic lateral sclerosis	3e-05	0.0012
Disease-activity	pDC	Pathways of neurodegeneration - multiple diseases	0.0001	0.0036
Disease-activity	pDC	Alzheimer disease	0.00015	0.0047
Disease-activity	pDC	Oxidative phosphorylation	0.0014	0.04
Disease-activity	pDC	Measles	0.0024	0.064
Disease-activity	pDC	RIG-I-like receptor signaling pathway	0.0028	0.068
Disease-activity	pDC	Hepatitis C	0.005	0.11
Disease-activity	pDC	Glutathione metabolism	0.0092	0.2
Disease-activity	pDC	Antigen processing and presentation	0.0099	0.2
Disease-activity	pDC	Collecting duct acid secretion	0.013	0.24
Disease-activity	pDC	NOD-like receptor signaling pathway	0.018	0.32
Disease-activity	pDC	Other types of O-glycan biosynthesis	0.019	0.33
Disease-activity	pDC	Human papillomavirus infection	0.022	0.35
Disease-activity	pDC	Type I diabetes mellitus	0.023	0.35
Disease-activity	pDC	Human cytomegalovirus infection	0.034	0.49
Disease-activity	pDC	Cellular senescence	0.036	0.49
Disease-activity	pDC	Diabetic cardiomyopathy	0.037	0.49
Disease-activity	pDC	Human immunodeficiency virus 1 infection	0.041	0.52
Disease-activity	pDC	Allograft rejection	0.044	0.52
Disease-activity	pDC	Graft-versus-host disease	0.044	0.52
Disease-activity	pDC	Retrograde endocannabinoid signaling	0.048	0.54
Disease-activity	Neu	Protein processing in endoplasmic reticulum	9.5e-06	0.0031
Disease-activity	Neu	Insulin signaling pathway	8.1e-05	0.013
Disease-activity	Neu	Autophagy - animal	0.00088	0.078
Disease-activity	Neu	Lipid and atherosclerosis	0.0011	0.078
Disease-activity	Neu	Spinocerebellar ataxia	0.0012	0.078
Disease-activity	Neu	Influenza A	0.005	0.24
Disease-activity	Neu	Glucagon signaling pathway	0.0054	0.24
Disease-activity	Neu	NOD-like receptor signaling pathway	0.0072	0.24
Disease-activity	Neu	Pathways of neurodegeneration - multiple diseases	0.0081	0.24
Disease-activity	Neu	Amyotrophic lateral sclerosis	0.0092	0.24
Disease-activity	Neu	Apoptosis - multiple species	0.0094	0.24
Disease-activity	Neu	Other glycan degradation	0.011	0.24
Disease-activity	Neu	Salmonella infection	0.011	0.24
Disease-activity	Neu	IL-17 signaling pathway	0.011	0.24
Disease-activity	Neu	Insulin resistance	0.012	0.24
Disease-activity	Neu	AMPK signaling pathway	0.013	0.24
Disease-activity	Neu	Longevity regulating pathway	0.013	0.24
Disease-activity	Neu	Fructose and mannose metabolism	0.013	0.24
Disease-activity	Neu	Long-term potentiation	0.015	0.25
Disease-activity	Neu	Shigellosis	0.016	0.25
Disease-activity	Neu	Non-homologous end-joining	0.019	0.29
Disease-activity	Neu	Epstein-Barr virus infection	0.02	0.29
Disease-activity	Neu	Inositol phosphate metabolism	0.023	0.32
Disease-activity	Neu	Amino sugar and nucleotide sugar metabolism	0.025	0.34
Disease-activity	Neu	RNA degradation	0.026	0.34
Disease-activity	Neu	Lysosome	0.03	0.34
Disease-activity	Neu	Pathogenic Escherichia coli infection	0.03	0.34
Disease-activity	Neu	RIG-I-like receptor signaling pathway	0.031	0.34
Disease-activity	Neu	Measles	0.031	0.34
Disease-activity	Neu	Choline metabolism in cancer	0.031	0.34
Disease-activity	Neu	Apoptosis	0.034	0.36
Disease-activity	Neu	Neurotrophin signaling pathway	0.035	0.36
Disease-activity	Neu	Necroptosis	0.041	0.4
Disease-activity	Neu	Alzheimer disease	0.043	0.4
Disease-activity	Neu	Nucleocytoplasmic transport	0.044	0.4
Disease-activity	Neu	Th17 cell differentiation	0.044	0.4
Disease-activity	Neu	Hepatitis B	0.047	0.41
Disease-activity	Neu	Spliceosome	0.048	0.41
Disease-activity	LDG	Parkinson disease	6.7e-05	0.011
Disease-activity	LDG	Huntington disease	9e-05	0.011
Disease-activity	LDG	Coronavirus disease - COVID-19	0.00011	0.011
Disease-activity	LDG	Pathways of neurodegeneration - multiple diseases	0.00024	0.014
Disease-activity	LDG	Pertussis	0.00027	0.014
Disease-activity	LDG	Insulin signaling pathway	0.00028	0.014
Disease-activity	LDG	Autophagy - animal	0.00046	0.019
Disease-activity	LDG	Alcoholism	0.00048	0.019
Disease-activity	LDG	Protein processing in endoplasmic reticulum	0.0015	0.043
Disease-activity	LDG	Prion disease	0.0015	0.043
Disease-activity	LDG	Necroptosis	0.0015	0.043
Disease-activity	LDG	Hepatitis C	0.0023	0.059
Disease-activity	LDG	Amyotrophic lateral sclerosis	0.0029	0.07
Disease-activity	LDG	NOD-like receptor signaling pathway	0.0033	0.072
Disease-activity	LDG	Lysosome	0.0035	0.072
Disease-activity	LDG	Pentose phosphate pathway	0.0039	0.076
Disease-activity	LDG	Influenza A	0.0044	0.08
Disease-activity	LDG	Chemical carcinogenesis - reactive oxygen species	0.0048	0.082
Disease-activity	LDG	Choline metabolism in cancer	0.0051	0.084
Disease-activity	LDG	Salmonella infection	0.0057	0.088
Disease-activity	LDG	Neurotrophin signaling pathway	0.008	0.12
Disease-activity	LDG	Mitophagy - animal	0.0085	0.12
Disease-activity	LDG	RIG-I-like receptor signaling pathway	0.0087	0.12
Disease-activity	LDG	Insulin resistance	0.0092	0.12
Disease-activity	LDG	Viral carcinogenesis	0.0099	0.12
Disease-activity	LDG	Thermogenesis	0.011	0.13
Disease-activity	LDG	Other glycan degradation	0.011	0.13
Disease-activity	LDG	Inositol phosphate metabolism	0.013	0.15
Disease-activity	LDG	Measles	0.015	0.16
Disease-activity	LDG	Alzheimer disease	0.019	0.2
Disease-activity	LDG	Glioma	0.02	0.2
Disease-activity	LDG	Apoptosis	0.023	0.23
Disease-activity	LDG	Shigellosis	0.024	0.23
Disease-activity	LDG	Pathogenic Escherichia coli infection	0.026	0.23
Disease-activity	LDG	Diabetic cardiomyopathy	0.026	0.23
Disease-activity	LDG	EGFR tyrosine kinase inhibitor resistance	0.027	0.24
Disease-activity	LDG	Proteasome	0.028	0.24
Disease-activity	LDG	2-Oxocarboxylic acid metabolism	0.03	0.25
Disease-activity	LDG	C-type lectin receptor signaling pathway	0.033	0.26
Disease-activity	LDG	Long-term potentiation	0.034	0.26
Disease-activity	LDG	Various types of N-glycan biosynthesis	0.036	0.27
Disease-activity	LDG	Vibrio cholerae infection	0.037	0.27
Disease-activity	LDG	Growth hormone synthesis, secretion and action	0.037	0.27
Disease-activity	LDG	Endocytosis	0.038	0.27
Disease-activity	LDG	mTOR signaling pathway	0.039	0.27
Disease-activity	LDG	Hepatitis B	0.042	0.28
Disease-activity	LDG	Longevity regulating pathway	0.044	0.29
Disease-activity	LDG	Glycolysis / Gluconeogenesis	0.047	0.3
Disease-activity	LDG	Spinocerebellar ataxia	0.047	0.3
